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Photoactivation is a physical process that allows using light-matter interaction as a 
precursor to induce a specific Physico-chemical reaction.  
This reaction is induced after the absorption of a photon, having a suitable 
wavelength, by specific photoactivable molecules. Such molecules act as a 
molecular machine that performs functions useful both for therapeutic purposes but 
also for the study of biophysical processes. The ability to have high temporal and 
spatial control is one of the main advantages of photoactivation. Therefore 
combining the photoactivation with appropriate optical methods, manipulation of 
living specimens at molecular precision is possible. 
Moreover, a set of photoactivable molecules is the key player in realizing super-
resolution microscopy, allowing the quantitative study of biological challenges at 
the subcellular scale. [1]  
This work of thesis focuses the attention on two classes of photoactivable 
molecules, i.e., caged compounds and photosensitizers, with the attention at 
applications in the neuroscience and photodynamic therapy fields, respectively. 
 
Caged compounds are realized via covalent appendage of a light-sensitive 
protecting group “the cage”  to a signaling molecule. In particular, it was used as a 
GABA caged molecule (RuBi-GABA).  One photon (UV-VIS light) and two-
photon (700-900nm) absorption were used to break the “cage” binding[2]. The 
uncaged molecule (GABA) becomes active and can bind the GABAA receptor site 
generating a Cl- current across the neuronal membrane that can be recorded using 
the Patch Clamp Technique. This approach allows controlling the neurotransmitter 




method and fluorescence microscopy coupled to the patch-clamp technique 
provides a useful approach to detect a selected biological target in a temporally and 
spatially confined way. In this thesis was analyzed how the change of physical 
parameters such as uncaging distance, exposure time, laser power, linear and non-
linear photoactivation influence the measurements, and here I determined how 
these parameters change concentration and volume of GABA release and 
consequently the GABAA response. Specifically, localization precision can be 
improved using advanced fluorescent optical methods such as super-resolved and 
non-linear fluorescence microscopy[3]. This allows exploring the release of caged 
GABA topically applied in situ at defined concentration and in a specific region of 
neuronal cells for mapping the localization and the functional distribution of 
GABAA receptors in cerebellar granule cells in vitro. Finally, it was possible to 
explore the responses generated by specifics drugs in different regions of neurons.  
 
Photosensitizers are photoactivable molecules that, after absorption of light, can 
produce reactive species of oxygen, which induce cell damage and death. When 
those molecules are targeted to cancer cells the process could lead to the death of 
tumor cells [4][5]. Such molecules are typically exploited in photodynamic therapy 
(PDT). 
This treatment modality is not invasive and explicates its function by the 
simultaneous presence of a PS, visible light, and tissue oxygen. Indeed, these 
specific molecules can target and localize in the neoplastic tissue and, upon 
photoactivation with visible light, they generate reactive oxygen species (ROS), 
causing confined damage [6]. 
The reactive chemical species, and in particular singlet oxygen (1O2), are 
characterized by an active region of the order of 0.02 μm  [7], where a series of 
reactions can produce oxidative damages and consequently cellular death for 
apoptosis or necrosis. The cellular death mechanism, such as apoptosis or necrosis, 
depends on (i) the cell line, (ii) the quantity of light, and (iii) the cell area in which 
the PSs accumulate [8].  Besides, these cellular damages could produce an immune 




A particular class of PSs, such as hypericin, phthalocyanine, porphyrin, and 
curcumin, are an object of study for PDT.  
However, a general characteristic and drawback of PSs is the low solubility in water 
and the aggregate formation, which impair their photophysical properties, such as 
the quenching of productive, excited states. To overcome this limit, PSs carriers 
were exploited. Among them, proteins offer several potential advantages. It has 
been demonstrated that PS molecules spontaneously bind internal hydrophobic 
cavities of particular proteins, preserving their monomeric, photoactive (both 
photosensitizing and fluorescent) state [12]. 
Proteins such as ApoMb and BSA were used as a carrier (ApoMb and BSA) for 
hypericin, phthalocyanine, porphyrin, and curcumin. These complexes were studied 
through advanced microscopical methods (spinning disk confocal, confocal, and 
STED microscopy) analyzing the difference in the use of PS or PS-protein complex, 
demonstrating how a protein can increase the PS efficacy. Therefore, were 
performed accumulation measurements, biocompatibility and bioavailability tests, 
colocalization measurements, and were studied the interactions of PSs with tumoral 
spheroids. 
In summary, the main goals of this work are: (i) the study of cellular tumor damages 
induced by photosensitizing molecules and its localization in cells and the increase 
of its efficacy using protein carriers exploit advanced microscopy technique (ii) the 
study of GABAA receptor with the use of GABA caged molecule developing a set-







Chapter 1: Photoactivation 
1.1  Photoactivation  theory 
 
1.1.1 Molecular structure 
To understand the spectroscopic characteristic of photoactivatable molecules, it is 
essential to have a quantistic approach to the molecular structure. The probability 
distribution of electrons in a molecular system is characterized by the wave 
function, 𝛹, and its evolution is described by Schrödinger equation (for a non-




Ψ(𝐫, t) = (−
ℏ2
2𝑚𝑒
∇2 + 𝑉(𝒓, 𝑡)) Ψ(𝐫, t)     (1.1) 
 
me and 𝑉 represent particle mass of and its potential energy, respectively.  
Solving the Schrödinger equation permits to find the presence of stationary states, 
also known as molecular orbitals. these states are described through time-
independent equations.[13] 
 
                                                   Ĥ|𝛹⟩ = 𝐸|𝛹⟩     (1.2) 
 
It is possible to solve this equation analytically only for the case of H+2 molecule, 
but using Born-Oppenheimer approximation, it is possible to solve for a more 
complex molecule. 
If we consider that nuclei move much slower than electrons in a molecule, then we 
can assume that electrons move in a fixed potential due to nuclei, while nuclei feel 
an average potential due to electrons. 
The Born–Oppenheimer approximation is very reliable for ground electronic states, 




The most straightforward approach is to consider  H+2  ion in which all motion is 













+ 𝑉(𝑧, 𝑍1, 𝑍2)     (1.3) 
where z is the electron position and Z1,2, of the two nuclei. It possible rewrite:   
𝐻 = 𝑇𝑒 + 𝑇𝑛 + 𝑉     (1.4) 
Schrödinger equation is: 
𝐻𝜓(𝑧, Z1, Z2) = 𝐸 𝜓(𝑧, Z1, Z2)     (1.5) 
splitting wavefunction 𝜓 in electronic (φ) and nuclear (χ) wavefunction 
 
𝜓(𝑧, Z1, Z2, ) = 𝜑(𝑧, Z1, Z2)𝜒(Z1, Z2)    (1.6) 
 





∇2 + 𝑉) 𝜑 = 𝐸𝜑     (1.7) 
where E is the total electronic and nucleus-nucleus repulsion energy for a stable 
nuclear conformation V is the potential energy of the electron in the field of the 






Fig. 1.1 Morse potential 
 
Despite Born Oppenheimer approximation, the solution of the Schrödinger 
equation for H2
+ is complicated. So, for solving more complicated molecules with 
more electrons, we need another approximation.  
It is possible to write H2
+ wavefunction such as linear combinations of hydrogen 
atomic orbitals: 
  
𝜑+ ≈ 𝛷𝑎 + 𝛷𝑏            𝜑
− ≈ 𝛷𝑎 − 𝛷𝑏            (1.8) 
 
Where Φa and Φb are hydrogen 1s-orbital of nucleus A and B.  The two cases 
represent the electron density given from constructive and destructive 
interference of nuclear wave function. This method is called LCAO (linear 
combination of atomic orbitals)  
For each of this wave function correspond two different energy orbital E+ and E-. 
The lower-energy orbital, given from φ+ wavefunction, is called a bonding orbital. 
The higher-energy orbital, given from φ- wave function, is called an antibonding 




energy, so this configuration it helps the bonding of two nuclei; when it is in its 
antibonding orbital, the molecule energy raises and the two nuclei tend to be forced 
apart. Under inversion, the wavefunction ψ+ remains indistinguishable from itself. 
In contrast, ψ- change its sign, so the first one is classified as having gerade 
symmetry and the second one ungerade [14]. 
 
1.1.2 Absorption of light 
An electronic transition is defined as an electron passage from a ground state of 
molecular orbital to an unoccupied orbital by absorption of a photon. In this case, 
the molecule is in an excited state. In absorption and fluorescence spectroscopy, 
two crucial types of orbitals are considered: the Highest Occupied Molecular 
Orbitals (HOMO) and the Lowest Unoccupied Molecular Orbitals (LUMO). [15] 
The light absorption is due to the dipole interaction of the electromagnetic wave 
with the dipole moment of the molecule. If Em and En are the energies of the initial 
and final molecular states respectively, it is possible to have absorption of light if 
and only if: 
 
𝐸𝑛 − 𝐸𝑚 = ℎ𝜈     (1.9)  
 
Were ℎ𝜈 is the photon energy. 
The transition probability from m to n state depends on the wavefunction of the 
ground and excited-state φm and φn, and of electric dipole moment operator μ: 
 
𝜇𝑚𝑛 = ∫ 𝜓𝑛𝜇𝜓𝑚𝑑𝜏     (1.10)   
Were dτ is the volume element. 
The dipole moment depends on three terms:  
- an electronic transition moment, due on the nature of the electron  
distribution in the initial and final electronic spatial wavefunctions 
〈𝑇𝑛|𝜇|𝑇𝑚〉 
- two overlap integrals related to the electronic spin 〈𝑆𝑛||𝑆𝑚〉 and the nuclear 





𝜇𝑚𝑛 = 〈𝜓𝑛|𝜇|𝜓𝑚〉 = 〈𝑇𝑛|𝜇|𝑇𝑚〉〈𝑆𝑛||𝑆𝑚〉〈𝜒𝑛||𝜒𝑚〉    (1.11)   
 
The electronic transition fulfills the Franck-Condon principle, that states that 
electron excitation by electromagnetic radiation occurs rapidly compared to nuclear 
motions. Thus, the nuclei remain permanently frozen during the transition. In this 
condition, the nuclear configuration remains the same during the transition. For this 
reason, the electronic transition is considered as a “vertical transition.”  
𝐹ranck-Condon factor ( ⟨ 𝜒𝑛|| 𝜒𝑚⟩ ) represents the overlap between the final and 
initial nuclear wave functions. 
 
Since the electronically excited state thus generated can have different structural 
properties compared to the ground state. Therefore some changes in the nuclear 





Fig. 1.2 Similar equilibrium geometry (a) different equilibrium geometry (b) 
 
 
When there is the same nuclear equilibrium configuration, in the ground and the 
excited state, the most probable transition is the 0-0 (Fig. 1.2a), In contrast, if the 
nuclear configuration is different, the 0-0 is no longer the most probable, and the 
transition at a higher vibrational state became more probable (Fig. 1.2b).  
This mechanism and the spacing of vibrational subbands together to electronic state 
distribution are fundamental for the shape of absorption spectra.[16] 
The transition dipole moment also contains the spin overlap integral. When one of 
the two electrons of opposite spins is promoted to a molecular orbital of higher 
energy, its usually spin unchanged so that the total spin quantum number 𝑆 = ∑ 𝑠𝑖  
remains equal to zero. Because the multiplicities 𝑀 = 2𝑆 + 1 of both the ground 
and excited states are equal to 1, both are called singlet state, denoted S0 for the 
ground state, and S1; S2 [etc.] for the excited states. This transition is called a 
singlet–singlet transition. Unchanging spin the spin overlap integral will be 
〈𝑆𝑛||𝑆𝑚〉 = 1. In some cases, the electron in singlet excited state can have a 
conversion that produces a spin inversion; having two electrons with parallel spins, 
the multiplicity will be 3. It is called the triplet state and is composed of three states 
of equal energy. In this case, spin overlap integral will be 〈𝑆𝑛||𝑆𝑚〉 = 0 
The electric dipole transition cannot induce changes in the spin state in the absence 
of spin-orbit coupling.[15] 
 
1.1.3 Relaxing from an excited state  
 
There are a variety of photophysical relaxing mechanisms for an excited molecule:   
- Radiative processes where deexcitation to lower energy states occur through 
the emission of electromagnetic radiation (fluorescence, phosphorescence) 
- Nonradiative processes where electronically excited states are transferred 




- Quenching processes (non radiative) where bimolecular interactions occur. 
In particular energy transfer of the excited state to other molecules take 
place. 
A photophysical process is distinct from a photochemical process in that the former 
involves only changes in quantum states of a molecule and not its chemical nature.  
The schematic diagram, called the Jablosky diagram, shown in Fig. 1.3, is useful to 





Fig. 1.3 Jablonsky diagram 
 
In this diagram are represented the singlet ground states, the first excited state, and 
the first excited triplet state. Each electronic energy level of fluorophores is split 
into vibrational energy levels. Arrows depict the possible transitions between states.  





The gap between the S0 and S1 electronic states is too large to have thermal 
excitation. At room temperature, thermal energy is not adequate to significantly 
populate the excited vibrational states. For this reason, we use visible light and not 
heat to induce fluorescence.  
After light absorption occurs, a fluorophore is excited to a vibrational level of the 
first two electronic levels. It rapidly relaxes to the lowest vibrational level of S1. 
This process is called internal conversion and generally occurs within 10–12 s or less. 
Since fluorescence lifetimes are typically near 10–8 s, the internal conversion is 
generally completed before emission. Hence, fluorescence emission generally 
results from a thermally equilibrated excited state, that is, the lowest energy 
vibrational state of S1.  
The return to the ground state typically occurs to a higher vibrational level of the 
ground state, which then quickly (10–12 s) reaches thermal equilibrium. An 
interesting consequence of emission to higher vibrational ground states is that the 
emission spectrum is typically a mirror image of the absorption spectrum of 𝑆0 →










Molecules in the S1 state can also undergo a spin conversion to the first triplet state 
T1. Emission from T1 is called phosphorescence and is shifted to longer wavelengths 
relative to the fluorescence because the triplex excited state has lower energy in 
comparison with S1 . Typically this phenomenon could be beaten by the back 
conversion to the excited S1 state leading to  "retarded fluorescence”. The 
conversion of S1 to T1 is called intersystem crossing.  
The transition from T1 to the singlet ground state is forbidden, and as a result, the 
rate constants for triplet emission are several orders of magnitude smaller than those 
for fluorescence, and its lifetime is usually longer of 10–6 s. [17] As shown in Fig 
1.4, there is a difference in the wavelength of the excitation and emission peak. This 
difference is due to the change in the equilibrium coordinates of the nuclear wave 
function that could be due to the interaction with solvent. Solvent molecules whose 
dipole moment interacts with the dipole moment of the fluorophore to yield an 
ordered distribution of solvent molecules around the fluorophore.  
Energy level differences between the ground and excited states in the fluorophore 
produce a change in the molecular dipole moment, which ultimately induces a 
rearrangement of surrounding solvent molecules. Solvent molecules assist in 
stabilizing and further lowering the energy level of the excited state by re-orienting 
(termed solvent relaxation) around the excited fluorophore in a slower process that 
requires between 10 and 100 picoseconds. This has the effect of reducing the energy 
separation between the ground and excited states, which results in a redshift (to 
longer wavelengths) of the fluorescence emission Fig 1.5. 
 Increasing the solvent polarity produces a corresponding significant reduction in 
the energy level of the excited state while decreasing the solvent polarity reduces 
the solvent effect on the excited state energy level. The polarity of the fluorophore 




Polar and charged fluorophores exhibit a far stronger effect than non-polar 
fluorophores.  
 
Fig. 1.5  Stock shift representation [17]. 
 
Fluorescence emission can be affected by the same mechanism that decreases its 
flurescence intensity, such as quenching. Quenching is due to different 
mechanisms. For example, collisional quenching occurs when the excited-state 
fluorophore is deactivated upon contact with some other molecule in solution, 
called the quencher.  




= 1 + 𝑘𝑞τ0[𝑄] 
K is the Stern-Volmer quenching constant that indicates the fluorophore sensitivity 
of quencher, kq is the bimolecular quenching constant, τ0 is the unquenched lifetime, 
and [Q] is the quencher concentration. [17] 
 
1.2 Photoactivation of the caged compound 
GABA neurotransmitter 
Neurotransmitters are molecules packaged in vesicles in presynaptic neurons, 
released in the synapse by fusion of the vesicles with the plasma membrane, and 




involved in the neuronal reuptake of the neurotransmitters and the regulation of 
their levels in the synaptic cleft belong to two significant superfamilies, High-
affinity glutamate and neutral amino acid transporter and Na+ and Cl– dependent 
neurotransmitter transporter. Transporters in both families play roles in reuptake of 
neurotransmitters like γ-aminobutyric acid (GABA), glutamate, and the 
monoamine neurotransmitters norepinephrine, serotonin, and dopamine. These 
transporters may serve as pharmacological targets for neuropsychiatric drugs. [18] 
Gamma-aminobutyric acid (GABA) is the primary inhibitory neurotransmitter in 
the mammalian central nervous system (CNS). It is known that GABA mediates 
most inhibitory transmission events in the vertebrate brain [19], and GABAergic 
signaling plays an essential role in the development of  CNS [20]. 
Some drugs can enhance inhibitory neurotransmission include benzodiazepines, 
barbiturates, and general anesthetics and are used as a sedative and for the treatment 
of some neurological diseases [21]. 
GABA Receptor  
GABA can interact on the different receptors as GABAA and GABAB types. [20]     
These receptors differ in molecular structure, signal transduction mechanism, 
distribution, function, and pharmacological profile. 
The object of the study of this work is the GABAA receptor. 
GABAA receptors are ligand-dependent protein channels and represent the primary 
mechanism by which GABA can transfer a rapid inhibitory signal (in the order of 
few milliseconds). 
Cl- is the ion for this receptor and fixes the value of the membrane potential 
(- 70 mV). 
Activation of this receptor reduces, through hyperpolarization, the probability of 
having an action potential that decreases the excitability of the cell. [22] 
The GABAA receptor is a pentameric complex composed of several subunits.  
There are 16 subunits, α1-6, β1-3, γ1-3, δ, ε, θ, and π [23] the combination of 
different subunit classes leads to the formation of GABAA receptors with different 
pharmacological properties. In vivo, generally, it is composed of the isoform 2α, 







Fig. 1.6 GABAA receptor structure 
 
GABAA Receptor presents several binding sites for different drugs such as 
benzodiazepines, barbiturates, neuroactive steroids, anesthetics, and convulsants 
that change the interaction with GABA neurotransmitter. 
Interaction of these drugs with GABAA receptor allows modulating anxiety, the 
excitability of the brain, muscle tonus, […] [24]. 
For these reasons, the GABAA receptor is an essential object of study for 
pharmacology.  
Uncaging (RuBi-GABA) 
Caged compounds are composed of biological effector molecules whose active 
functionality has been chemically masked with a photoremovable protecting group.  
These compounds produce a high impact of interest in neuroscience,  because of 
the capability of the localized release of neuroactive molecules in a well-defined 
area of a neuron; this represents a new approach for the study of receptor 




Caged molecules must have the same characteristics as those used for neuroscience 
applications. It must not produce a response before illumination and must be 
hydrolytically and enzymatically stable during the experiment. 
It must not be agonist or antagonist for cellular receptors and must not be toxic. 
Uncaging has many useful features and advantages compared to other technologies 
for changing solute concentration around or inside living cells. These include: 
1. Intracellular release. Being cell transparent, the inner part of the cell is accessible 
to uncaging technique  
2. Speed of release. Uncaging time is of the order of sub-micro seconds to 
milliseconds, so it is swift and allows quantifying the channel kinetics.  
3. Timing of release. The caged compound is inert until photoactivated. It can 
activate molecules at a specific time during the experimental time course. 
4. Location of release.  The position and the volume of photoactivation are defined 
and confined. 
5. Quantification of release. It is possible to calibrate in a specific experimental 
parameter uncaging efficiency. It allows quantifying the number of uncaged 
molecules. [26] 
 
There is a large variability of a different caged and neuroactive molecule, for 
example, GABA [2], glutamate [27], nicotine [28] […] in this work of thesis the 
object of the study is caged RuBi-GABA, a compound where GABA is bound to 
ruthenium-bipyridine- triphenylphosphine.  
 
Fig. 1.7 RuBi-GABA structure in the cage and uncaged form [2] 
 
This molecule presents different advantages: in fact, it has a high quantum yield of 




to prevent DNA damage, and it is possible to increase light penetration [2]. At last, 
but not least, this molecule is photoactivable using two-photon excitation. 
 
1.3 Photoactivation of Photosensitizer   
Photodynamic therapy  
Light is used for the treatment of various diseases over 3000 years. Some 
civilizations, such as Egyptians, Indians, and the Chinese, used light for the therapy 
of psoriasis, rickets, and vitiligo. In Denmark, at the end of the XIX century, Niels 
Finsen discovered that red light allows treating smallpox pustule to prevent its 
formation, while the use of ultraviolet light coming only from the consent to treat 
cutaneous tuberculosis. This was received by modern "phototherapy" so that in 
1903 Finsen was awarded the Nobel Prize for his discoveries. 
 
 
Fig. 1.8  History of photodynamic therapy [6] 
 
Furthermore, more than 100 years ago, researchers observed that cell death could 
be induced by the combination of light and certain chemicals. In particular, in 1900, 
the German medical student Oscar Raab observed that the simultaneous presence 
of acridine and light of specific wavelengths has a lethal effect on some biological 
matter, including a kind of Paramecium. In conclusion, this therapy exploits three 
individually non-toxic components which, combining appropriately, can induce 
damage to cells and tissues [6]: 
 - A photoreactive agent called photosensitizer; 




- Tissue oxygen.  
Photodynamic therapy offers several advantages over traditional methods of 
anticancer treatment, such as surgery, radiotherapy, or chemotherapy. Since it is 
possible to direct light activating photosensitizers towards the neoplastic tissue, 
using modern optical fibers and various types of endoscopes [29], the method is 
less invasive.  However, the primary advantage of this technique is given by the 
photosensitizing agent. With a suitable carrier, It can accumulate with a  and can be 




How to act photodynamic therapy 
Clinical treatment of PDT can be divided into four phases: 
- Administration of the drug; 
- Accumulation in the tumor; 
- Activation of the photosensitizer; 
- Generation of cytotoxic species and cell death; 
When a photosensitizer is illuminated with visible light of appropriate wavelength, 









As shown in chapter 1.1.3, some molecules can undergo inter-system crossing 
(ISC) from singlet to triplet state, S1 -> T1. This process, prohibited by the selection 
rules, is favored by spin-orbit coupling effects. The further de-excitation in the 
ground state S0 requires a second prohibited transition. Therefore, the lifetime of 
the T1 species is much longer, of the order of micro / milliseconds, and is enough 
to allow energy transfer with surroundings molecules, hence generating cytotoxic 
species. In particular, two different reactions can be involved: 
 
Type I reactions. 
A charge transfer occurs from the photosensitizer in the T1 excited triplet state to 
biological substrates (unsaturated lipids, steroids, aromatic amino acids), with 
consequent formation of radical species, which in turn react with oxygen molecules 
to produce reactive oxygen species. These intermediates are highly reactive and 
strongly oxidizing, such as superoxide anion, hydrogen peroxide, and hydroxyl 
radical. 
Type II reactions.  
There is a direct energy transfer from the photosensitizer in the triplet state to the 
molecular oxygen (3O2) to form singlet oxygen (
1O2) which, has a crucial role in 
the in anticancer treatment by PDT. 
 
The two reaction types do not occur in a mutually exclusive manner, but they can 
contribute together to the final therapeutic effect.  
The magnitude of oxidative damage caused by ROS strictly reflects the intracellular 
localization of the photosensitizer, due to the short lifetime of ROS that prevents 
them from traveling longer than a few tens of nanometers. In particular, oxygen in 
the singlet state has a half-life few than 4 μs, and this time interval allows it to 
spread to a distance not longer than 0.02 μm. So, the oxidative damage can be 
precisely confined to the diseased cells targeted by the therapy, preserving the 






A photosensitizer is defined as an atom or a molecule that absorbs radiant energy, 
usually visible light, consequently move to an excited electronic state, and 
subsequently transfers the excitation energy to another atom or molecule. 
There are several features that a photosensitizer must have to be suitable for 
photodynamic therapy, including [7][30]: 
1) It must be available in pure form, and of known chemical composition; 
2) It must be synthesizable from precursors available and easy to reproduce; 
3) A high quantum yield of singlet oxygen production (ΦΔ); 
4) A high absorption in the red region of the visible spectrum (680-800 nm) with a 
high molar extinction coefficient (ε) of the order of 50,000 - 100,000 M-1 cm-1. 
This range is determined by the fact that in the organism, below the 680 nm 
scattering phenomena and strong absorption by endogenous chromophores are 
observed, which limits the penetration of light. On the other hand, at wavelengths 
exceeding 900 nm, light has not enough energy to generate singlet oxygen. 
5) Photostability and no toxicity in the absence of light (dark toxicity) in order to 
prevent side effects at high doses; 
6) Sufficient energy of the excited triplet electronic state, which must be higher than 
94 kJ mol to allow the transition between the fundamental state of oxygen and the 
first excited state of singlet; 
7) A preferential biodistribution in tumor tissues; 
8) A quick molecule elimination to avoid skin photosensitization effect; 
9) Excellent solubility in pharmaceutical formulations and in body fluids 
The first generation of photosensitizers used for PDT was a derivative of 
hematoporphyrin. It consists of a complex mixture of porphyrins in the form of 
monomers and oligomers. Thus Photofrin® was formulated in 1995 was approved 
by the FDA as a photodynamic agent for PDT and had high popularity for the 
treatment of various tumors [30]. Nevertheless,  Photofrin® does not respond to 
many characteristics proper to an ideal photosensitizer: 
- It is difficult to reproduce the composition mixture  
- There is a modest biological activity, with a low molar extinction coefficient in 




- High doses are necessary.  
- Low selectivity for the target tissues. 
This leads to numerous side effects, such as skin photosensitization [7]. 
Limitations of first-generation photosensitizers, bring production of new molecules 
with better properties, leading to developing second-generation photosensitizers 
which have a higher absorption and molar extinction coefficient at longer 
wavelengths and high chemical purity.  
The major limitation of this second generation of drugs is the inefficient selective 
accumulation of photoactive agents in the diseased tissue and its aggregation 
propensity, which leads to significant side effects. 
To overcome this problem, the use of several biomolecules such as: monoclonal 
antibodies, lecithins, peptides, hormones, folates, and ligands, that are selective for 
receptors overexpressed in tumor cells combined with the photosensitizer gives a 
major selectivity.  the photosensitizer development leads to giving higher drug 
selectivity combining them with biomolecules, such as monoclonal antibodies, 
lecithins, peptides, hormones, folates, and ligands for receptors overexpressed by 
tumor cells. Thus was born the third photosensitizer generation. This is based on 
the combining second-generation photosensitizers with carriers, allowing: 
- Make soluble molecules in water-based fluids (increase bioavailability); 
- Giving selectivity (targeting); 
- Increase the fluorescence emission; 
- Increase biocompatibility. 
 
Protein carrier system  
Protein carrier systems result to be an interesting solution for the delivery of 
photosensitizers. Since we choose proteins that are endogenous in the organism, the 
biocompatibility is fully preserved, minimizing undesired effects. Nevertheless, the 
use of proteins could allow a simple binding (see chapter 3.10). 






Myoglobin is a globular protein that can bind oxygen. It is present with a high 
concentration in human muscles and its function of oxygen reserve. 
Myoglobin was the first protein whose three-dimensional structure was determined 
through X-ray crystallography. 𝛼-helices mostly form myoglobin joined together 
by folds to form a globular structure. In particular, it consists of a single polypeptide 
chain of 153 amino acid residues and has a size of 45x35x25 Å and a molecular 
weight of 17,000 Da. To this polypeptide chain to which heme (Fe-protoporphyrin 
IX) is covalently attached and the iron atom of the heme is directly bonded to the 
proximal histidine (His93) [31] 
About 70% of the structure of myoglobin is organized in the form of eight α-helices, 
wrapped around the heme and histidine-93 called proximal (below) and histidine-
64 called distally (above); while the rest of the polypeptide chain forms folds and 
loops. Four cavities are present in the protein, determined by Xenon diffraction X-
linked studies, stylized in the figure as black spheres [32].  
      
 





The ability of myoglobin to bind oxygen depends on the presence of a prosthetic 
group, called heme. The red color of the muscle and blood is due to the presence of 
the heme, consisting of a non-protein organic component and a central ferrous ion. 
The organic component is called protoporphyrin and consists of four pyrrole rings 
linked by methyl bridges. Four methyl groups, two vinyl groups, and two 
propionate side chains are bound to the tetrapyrrolic ring thus formed. The iron 
atom is located in the center of protoporphyrin and is linked to the four nitrogen 
atoms of the pyrrole rings. When myoglobin is deprived of its heme cofactor, the 
remaining protein matrix is called apomyoglobin. 
Apomioglobin can be derived from myoglobin with a chemical protocol that 
exploits a partial acidic denaturation of the protein [33]. It is generally used for 
studies and developments of complexes with molecules different from heme bound 
within the protein cavity. 
 
Albumin 
Serum albumin is an abundant multifunctional protein and is the main protein 
component of blood plasma, but it can also be found in body tissues and secretions. 
The primary role of albumin is to transport fatty acids. Thanks to its versatile ability 
to bind various molecules and its high concentration in the body, it has a series of 
additional functions, which include the maintenance of osmotic blood pressure and 
the detoxification of the organism from carcinogenic metabolites, such as bilirubin 
[34]. 
Albumins are a monomeric protein composed of 585 amino acids with a total 
molecular weight of 66400 Da. The protein is 67% α-helicoidal and utterly free of 
β-sheet. They are organized into three homologous domains (named I-II-III), and 
each of these is composed of two subdomains (A and B) that share common 
structural elements. A total of 17 disulfide bridges, which are exclusively inside the 





Fig. 1.11  (a)Albumins structures and (b) binding sites. 
 
The albumin's crystalline structure revealed six possible binding sites for fatty acids 
and showed that a conformational change in the protein accompanies bonds with 
one of these. In five of the six sites (numbered 1-5), where there is a high electron 
density, fatty acids are bound. The sixth site at the interface between IIA IIB, in 
which there is a fragmented electron density, does not allow to host an entire 
molecule [34]. 
Two of these five sites are particularly crucial for reversibly binding many drugs. 
The first is found in the IIA subdomain, called the Drug 1 site, in which abundant 
heterocyclic compounds are bound, mostly without a carboxyl group. The second 
site, called drug site II, is located in the IIIA subdomain and is preferred by 
compounds with an aromatic ring or carboxylate groups which have a very large 
conformation [35].  
 
Targeting 
Targeting is based on the use of carrier systems. It transports drugs selectively to 





• Passive targeting. It is observed that photosensitizer accumulation in tumors site 
increase with its hydrophobicity. However, hydrophobic PSs show aggregation 
problems, so intravenous treatment is dangerous. Therefore, most of the PSs 
currently in use are encapsulated within hydrophilic molecules or structures such 
as liposomes, protein, polymer, and particles. Furthermore, these formulations 
showed an increase in photosensitizer concentration in tumors [36]. 
Passive targeting of vector and encapsulated drug is possible thanks to the 
physicochemical properties of the construct, e.g., size, hydrophilicity, and surface 
charge. Such parameters determine its biodistribution. Another essential 
characteristic is the alterations of physiological conditions caused by neoplastic 
tissue. It can produce severe damage to the lymphatic tract, which allows further 
accumulation of the molecules transported in the tumor interstices. This particular 
concept, called the "EPR effect" (Enhanced Penetration and Retention), explains 
how carriers passively reach the tumor releasing the encapsulated molecules in the 
desired site  [37]. 
• Active targeting. This takes advantage of the altered density of some receptors in 
tumor cells allowing the use of specific carriers to target photosensitizers [38]. 
For example, monoclonal antibodies can be exploited to give photosensitizer 
selectivity. The idea develops around the recognition of these antibodies for some 
overexpressed markers on the tumor cell surface that can be used as a "linker" 







Chapter 2: Microscopy and 
electrophysiological Methods  
 
 
2.1 Advanced fluorescence microscopy and nanoscopy  
Microscopy allows studying objects that are too small for the naked eye. A 
microscope is an optical system that transforms an ‘object’ into an ‘image’. The 
idea is to make the image much larger than the object, that is magnifying it, and 
exist different microscopy techniques in which this can be done [40], such as: 
- Atomic force microscopy uses a cantilever to probe the surface of the sample. 
At the end of the cantilever, a sharp tip is mounted to sense the force between the 
sample and tip.[41]  
This technique offers a fully three-dimensional view of the sample’s surface, 
without requiring a coating that alters the sample. So, AFM result suitable for 
biological samples analysis.[42] 
- Electron microscopy is based on the use of an accelerated electron beam for 
investigating the sample. Thanks to shorter wavelengths of radiation this technique 
allows a high-resolution level. There are two main classes of microscopy: scanning 
electron microscopy (SEM) and transmission electron microscopy (TEM). Both of 
them are exploited for 2D and 3D materials characterization[43]. At the simplest 
level, a SEM can be thought of as providing images of external morphology, while 
TEM probes also the internal structure of solids.[40] 
- Optical microscopy exploits visible light  (400-700nm) and its interaction with the 
matter to acquire an image of the sample. 
The use of visible light results particularly interesting for biological specimens. It 
is not invasive and allows three-dimensional subcellular studies in physiological 




Numerous transmitted light microscopy approaches such as phase-contrast, 
differential interference contrast (DIC), and polarized microscopy allow enhancing 
the inherent contrast of living specimens in order to make some details visible. 
Nonetheless, the exploitation of fluorescence results particularly interesting. This 
technique exploits some engineered fluorescent indicators that have the capability 
to bind some specific target, e.g., proteins, lipids, or ions. Their use was the biggest 
step forward in order to study cell physiology. The use of  a fluorescence 
microscope has the aim of being specific, increasing image contrast and spatial 
resolution. Consequently, most of the recent advances with fluorescence 
microscopy have sought to improve image quality by addressing the fundamental 
problem of image resolution, which is determined by noise, contrast and diffraction 




Point spread function 
Position accuracy refers to the precision with which an object can be localized in 
space. Spatial resolution is defined as the capability to discriminate two separate 
objects from a single one. [45] 
The point spread function (PSF) can be considered a measure of the resolving power 
of an optical system. The smaller the point spread function, the better the resolution 
will be. As the name implies, the point spread function defines the spread of a point 
source. If we have an infinitely small source of light, it will appear with a finite 
size. 
The image I(x) of a specimen produced by an optical microscope can be described 
as a convolution between the object (specimen) O(x) and the point spread function 
P(x):  





The PSF depends on the optical system but can be locally distorted because of 
aberrations introduced by the specimen or imperfections of the optical setup.  
Neglecting the aberration components, it is possible to estimate the diffraction limit. 
This implies that optical resolution is ultimately limited by the wavelength of light 
and focusing power. 
The image of an infinitely small luminous point object is not infinitely small but is 
a circular Airy diffraction pattern with a bright central disk and progressively 
weaker concentric dark and bright rings. The radius rAiry of the first dark ring around 
the central disk of the Airy diffraction pattern depends on the wavelength of light, 






Following Rayleigh criterion, that relies on the assumption that the two-point 
sources radiate incoherently, two points of light separated by a distance d  will be 





Introduction: from wide-field to confocal 
The most simple fluorescence microscope is the Wide-field microscope. It works 
illuminating all the samples with the light of suitable wavelength and the response 
of the sample, in fluorescence, is collected by a camera. The fluorescence is 







Fig. 2.1 Wide-field microscope scheme. [47] 
 
Wide-field microscopy presents several advantages. Being all the image area 
illuminated at the same time it allows faster imaging limited only by camera 
acquisition capabilities. Wide-field imaging generally allows lower excitation 
power that brings less photobleaching and phototoxicity.  
However, being optics governed by diffraction and collecting fluorescence of 
different out of focus planes in a single image, the final image has both a limited 
spatial resolution and a low contrast respectively. The lateral resolution is defined 
by Abbe’s law and two nearby objects can be resolved following, for instance, the 
Rayleigh criterion, [44] three-dimension sectioning is also possible and can be 
achieved by exploiting computational methods based on deconvolution. [48] The 
more advanced deconvolution methods attempt to reassign this out-of-focus light 
to its point of origin (i.e., converting airy rings back into single point sources of 
light); the resulting image should be sharper with better contrast and under certain 





Confocal microscopy is the first step towards higher resolution. Differently from 
Wide-field microscopy, it allows rejection of the out of focus signal thanks to the 
use of the pinhole, and it improves contrast, resolution and enables 3D mapping of 
the specimen. [47] 
 
Fig. 2.2 confocal microscope scheme. [47] 
 
The small pinhole is placed in a conjugate focal plane. This allows, to the only 
photons, emitted in the focal point, to pass through the pinhole for being recorded. 
Both any light outside of the focal plane and the scattered light is blocked by the 
screen. [50] This microscope brings in the concept of point-by-point scanning of 




This technique allows imaging the specimen one “point” at a time. To create an 
image of the specimen, the focal spot is rapidly and serially scanned in the X–Y 
plane, usually using a galvanometric mirror [51] or a stage motion (Marvin Minsky 
patent 1957). 
Point by pointing it fluorescence signal pass from pinhole and a dichroic mirror and 
is collected by a sensitive detector such as a photomultiplier. The fluorescence 






Disk scanning uses an alternative design. It is composed of a spiral-perforated disk, 
i.e., a Nipkow disk. Such a disk contains thousands of pinholes arranged in a spiral 
track. When the disk is spinning, the moving pinholes could cover the whole field 
of view, and signals were acquired by CCD camera. By spinning thousands of 
points simultaneously, the Nipkow disk can achieve a real-time confocal image.  
[52][50] In comparison to laser-scanning, this approach results faster with less 
bleaching and photo-toxicity.  
 
 
2.2 Super-resolution Fluorescence Microscopy  
A confocal microscope could reach and, to some extent, overcome the resolution 
limit of a lens. Considering a confocal microscope equipped with perfect lenses, 
optimal alignment, and large numerical apertures, the optical resolution is 
approximately half of the wavelength of the light used. This limit means that 
cellular structures and objects that have dimensions of at least 200 to 350 nm could 
be resolved by light microscopy. How it is understandable, the majority of the 
fundamental biology of cells happens at the dimension of macromolecular 
complexes ranging from tens to a few hundred nm.[53] This challenge produced an 
extensive study on the possible methods for overtaking the diffraction limit that 
culminated in 2014 with the Nobel prize awarded to Stefan Hell, Eric Betzig, and 







Fig. 2.3 PSF of different microscopy technique. [53] 
 
 
Recent innovations have led to the development of three leading alternatives for 
super-resolution microscopy that effectively break this diffraction limit: stimulated 
emission depletion microscopy (STED), stochastic optical reconstruction 
microscopy (STORM) / photoactivation localization microscopy (PALM), and 
structured illumination microscopy (SIM), .[57][58] 
- STED exploits stimulated emission promoted by a second laser beam to turn 
off fluorescence emission of fluorophores located in the surrounds of the 
excitation center, allowing to sharpen the excitation PSF (see the following 
section for more details). [59–61] 
- PALM/STORM uses photo-switchable fluorescent dyes that allow the 
separation in time of activation and detection of single molecules. Since the  
activation process is achieved randomly in space, it is possible to localize 
each fluorescent molecule and, therefore, each protein or structure, which is 
attached. The localization of each fluorescent molecule will have an 
uncertainty determined by the PSF and the number of photons emitted N, 





where Δloc is the localization precision, and Δ is the size of the PSF. Since 
the localization precision depends on N the final resolution limit is only 
defined by the label itself. [62] 
- SIM uses a series of sinusoidal striped excitation patterns with a high spatial 
frequency to illuminate the sample. Such a structured illumination allows 
retrieving higher spactial frequencies than a conventional microscope. The 
illumination pattern is typically generated by laser light passing through a 
movable optical grating and projected via the objective onto the sample. The 
method requires the acquisition of an image for each position and rotation 
of the pattern. The recorded images are linearly processed to extract the high 
spatial frequencies that are the smallest details and to generate a 
reconstructed image with twice the standard resolution. [63] 
STED Microscopy 
A typical STED nanoscope is based on a confocal microscope. It needs at least two 
coaligned laser beams: one for the excitation and a second for the fluorescence 
depletion. STED microscopy is based on the saturation of the stimulated emission 
process, which allows the instantaneous de-excitation of the excited fluorophore. 
The technique is realized illuminating the sample with a gaussian excitation beam 
aligned with a depletion beam, called the STED beam. This latter beam has a donut 
shape with a zero intensity at the center. This particular shape is obtained using a 
vortex phase plate. The two-beams combination allows shrinking the effective PSF 
depending on the reached saturation level of stimulated emission process, thus on 
the depletion beam power. Current experimental setups routinely achieve a 







Fig. 2.4 STED excitation, depletion beam, and PSF. [53] 
 
Lasers have a primary role  in STED microscopy. Quenching is optimized when 
depletion occurs shortly after fluorophore excitation, so STED microscopy is 
typically implemented with  pulsed lasers. [60]  
In a pulsed STED microscope, while the donut should always show a proper zero 
at the center, the depletion pulse must be synchronized with the excitation one and 
have a correct duration. A pulse width of τSTED 20–30ps would exploit the 
available STED power maximally and would yield the steepest decrease of the 
probability of spontaneous decay with increasing saturation factor . [64] 
Therefore, to obtain an excellent Spatio-temporal STED alignment, we take 
particular care on polarization, pulses delays, optical stability, and beam 
alignment.[61] 
Another critical parameter in STED microscopy is the wavelength of the depletion 
beam. The STED beam stimulates the emission of fluorophores, instantaneously 
bringing them to the ground state emitting a photon of the same wavelength of the 
depletion beam, so photons in this spectral region will be filtered out. For this 
reason, the wavelength of the depletion beam should be red-shifted to the tail of the 
fluorophore emission. However, we should consider that higher is the fluorescence 
emission probability in a determinate spectral region and higher is the probability 




To overcome the diffraction limit, the stimulated emission process should saturate. 
Saturation allows widening the donut area, so that the spontaneous fluorescence 
emission can occur only in the very center of the excited volume. Thus, PSF 
becomes smaller with the increase of the depletion beam power. The final 





where I is the intensity of the STED beam, and the saturation intensity IS is the 
intensity required by the STED beam to quench the spontaneous fluorescence 
emission by half. [59] 
 
2.3 Multiphoton Fluorescence Microscopy  
Multiphoton microscopy is a technique that, like confocal microscopy, allows us to 
have optical sectioning capability avoiding out of focus light. 
For the one-photon excitation (1PE) process, a dye could absorb a single photon of 
a suitable wavelength reaching the excited state.  Multiphoton excitation (MPE) use 
longer excitation wavelengths. MPE requires the simultaneous absorption of 
multiple photons so that the sum of their energies reaches the same values of the 
1PE case. To realize the condition of simultaneous absorption, it is necessary a high 
photon density so that two or more photons can interact with the fluorophore in a 
time lower than 10-17 s. [17] 
Considering two-photon excitation, the probability pa that a fluorophore in the focus 












Where na is the number of absorbed photons per molecule, 𝛿  the two-photon cross-
section, τp the laser pulse width, 𝑓𝑝 the pulse repetition rate, N.A. the numerical 
aperture, ‹ P › the average incident power, ℏ the Plank constant, c the speed of light 




Thanks to the dependence of 2PE from the second-order of the excitation power, in 
a sharply focused excitation beam, the excitation probability outside the focal 
region falls off. Considering the homogeneous distribution of chromophores and a 
Gaussian beam, about 80% of the two-photon absorption at λ= 700 nm occurs in a 
volume of ellipsoidal shape with 0.3 μm of diameter and 1 μm of length that 
correspond to 0.1 femtoliters in volume (considering an objective lens with an 
NA = 1.4). This means that 2PE is confined to the focal volume providing excellent 




Fig. 2.5 1PE (left) and 2PE (right) [47] 
 
Most fluorophores under continuous illumination photobleach rapidly, so localized 
excitation is an advantage. In 1PE, light is absorbed in all sample depths, so 
photobleaching occurs in all planes across the double cone. With 2PE we avoid out-
of-focus excitation and then photobleaching and photodamage do not occur with 






Fig. 2.6 Photobleaching of rhodamine with one- (left) and two-photon excitation 
(right). [17] 
 
Since in two-photon microscopy we double the conventional excitation wavelength, 
the spectral region used will be approximately in the spectral window between 700-
and 1000 nm. [66] 
Longer wavelegths allow an improved penetration depth [67] and a reduced 
photodamage in living specimens. Moreover, the quadratic behaviour gives a 
resolution increase of approximately √2 compared to the diffraction-limited spot of 
excitation light. However, 2PE cannot be considered a genuine super-resolution 
because the longer wavelength causes an increase of diffraction spot size of a factor 
of 2 in comparison of single-photon excitation. [68] 
 
2.4 Electrophysiology  
 
Bioelectromagnetism 
Bioelectromagnetism is a discipline that examines the electric, electromagnetic, and 
magnetic phenomena that arise in biological tissues. It is based on Maxwell's 
equations and the principle of reciprocity. Maxwell's equations connect time-
varying electric and magnetic fields. While, the principle of reciprocity affirms that 
the source and the measurement sites may be swapped without a change in the 
detected signal. Bioelectric phenomena of the cell membrane are fundamental in 




cellular potential is regulated through membrane ion channels, and, for example, 
allows communication among cells in the nervous system. Erwin Neher and Bert 
Sakmann won the Nobel prize in 1991 “for their discoveries concerning the 
function of single ion channels in cells” and for the invention of the patch-clamp 
technique.  This technique allows measuring the electric current from ion channels, 
studying bioelectromagnetism and molecular biology, bringing crucial information 
for the development of new pharmaceuticals.[69] 
 
Patch-clamp technique 
The patch-clamp technique allows the electrophysiological measurements of 
currents through ion channels in the cell membrane. This technique allows us to 
record the activity of native channels in their natural environment and to investigate 
both the ion channel conductance and dynamic behavior.  Thanks to this technique, 
new classes of ion channels were discovered, and their physiological role in cells 
was determined. With patch-clamp technique is possible to observe, in real-time, 
the changes in the activity of a single channel, including changes in conductance 
(the rate of ions going through the channel) and kinetic properties (the speed with 
which a channel opens and closes) in response to a pre-set stimulus. [70] 
In this technique, a small heat-polished glass pipette is pressed against the cell 
membrane, forming an electrical seal.  The resistance of the seal is important 
because it determines the level of the background noise of the current trace recorded 
during the measurement. Typically, a good resistance has a value ranging from 10 
to 100 MΩ guaranteeing a low-level noise. [71] 
There are five primary methods usable in patch-clamp experiments in Fig. 2.7 ; 
1. Cell-attached recording 
2. Whole-cell configuration  
3. Outside-out configuration  






Fig. 2.7 Different methods of patch-clamp. [70] 
 
All the procedures have, as a starting point, the cell-attached configuration that it is 
obtained as follows:  using a microscope, after choosing an isolated cell, the patch 
pipette is moved towards that cell surface, while a low-voltage square pulse is 
applied to the pipette. When the pipette touches the membrane, there is an increase 
in resistance, and after a suction, a tight seal is formed [70]. This configuration 
allows recording a single-channel current from the sealed patch with the intact cell 




configurations. It is possible to break, after a suction, the membrane between the 
pipette solution and the cytoplasm, obtaining the whole-cell configuration. This 
allows measuring currents of all the cellular membrane.  From this configuration, it 
is possible to obtain the outside-out patch, which is got excising the pipette slowly 
away. With this method, the outside of the cell membrane may be exposed to the 
bathing solution; therefore, it may be used to investigate the behavior of a single 
ion channel activated by the extracellular part of the receptor.  
 
Another approach is to excise the seal from the cell by suddenly pulling the pipette 
away from the cell after reaching the cell-attached. This method is called the inside-
out patch because the inside of the plasma membrane is exposed to the external salt 
solution. [72] The use of this approach is useful to investigate the cytoplasmic 
regulation of ion channels (see Fig 2.7). [69] 
 The last configuration is the perforated-patch configuration. It is similar to the 
whole-cell configuration and can be reached from the cell-attached configuration 
providing that the pipette contains a small amount of an antibiotic that allows the 
holing membrane. [70]  
For the measurement of ion currents across the membrane, the patch-clamp 
technique uses a specific amplifier based on a current-to-voltage converter circuit, 
which transfers the pipette current into an equivalent output voltage. [73] 
In practice, the amplifier measures the membrane voltage and compares it to a pre-
set voltage (V) defined by the channel property. When a current is activated, there 
is a voltage change of a value Vi. To compensate for this change current of 




















Chapter 3: Materials and Method 
3.1 Chemicals 
Zinc-phthalocyanine (ZnPc)  and Hypericin  (HYP) stock solutions were prepared 
by dissolving molecules powder in dimethylsulfoxide (DMSO). Then, we 
determined, using the molar extinction coefficient and Lambert-Beer law, the 
concentration of molecules solved through a spectrophotometer.  
3.2 Spinning disk 
Spinning disk confocal microscopy utilizes multiple pinholes to project a series of 
parallel excitation light beams onto the specimen in a multiplexed pattern that is 
subsequently detected after fluorescence emission passing through the same 
pinholes. The main features of this technique are (i) the high-speed imaging of 
living cells, (ii) lower photobleaching, and (iii) low phototoxicity due to the use of 
multiple excitation beams that needs only low laser power. However, it is sufficient 
for exciting sample fluorescence. The microscope is composed by a confocal unit 
Nikon TiE inverted Microscope equipped with an Okolab incubation system, and 
four excitation lasers (405nm, 488nm, 561nm, 640nm). The system is equipped 
with a Yokogawa CSU-X1 spinning disk containing about 20,000 pinholes and a 
second spinning disk containing the same number of micro-lenses to focus the 
excitation laser light. The fluorescence light is collected by an Andor EMCCD 
camera Ixon 897. Therefore, we image the specimens sequentially exciting at 561 
nm and 640 nm, and detecting in the spectral windows 575 - 625 nm and 670 - 740 
nm, respectively. 
3.3 STED nanoscopy 
STimulated Emission Depletion nanoscopy is composed of a custom made setup 
equipped with a supercontinuum pulsed laser source (ALP-710-745-SC, Fianium 
LTD, Southampton, UK) [59]. The excitation wavelength was selected by means 
of an acousto-optic tunable filter (AOTF), while STED wavelength was predefined 




of about 100 ps. In all the experiments, we used 566 nm of excitation and 715 nm 
of the STED beam. The donut shape of the STED beam was realized by a vortex 
phase plate (RPC Photonics inc., Rochester, NY, USA). The beams are scanned on 
the sample by galvanometric mirrors (Till-photonics, FEI Munich GmbH, 
Germany), focused by an HCX PL APO CS 100x 1.4NA oil (Leica Microsystems, 
Mannheim, Germany) objective and fluorescence is collected by an avalanche 
photodiode (SPCM-AQRH-13-FC, Excelitas Technologies,  Vaudreuil-Dorion, 
Quebec, Canada) in the spectral window 670-640nm. The STED efficiency had 
been previously assessed by measuring the fluorescence depletion curve [74] 
 
   
3.4 Uptake Analysis  
To study PSs accumulation we have marked cells with “CellMask™ Deep Red 
Plasma Membrane Stain” (Thermofisher, USA), characterized by excitation and 
emission wavelengths (λex = 649 nm, λem = 666 nm) that are longer than Hyp 
wavelengths (λex = 550 nm, λem = 600 nm), allowing to separate the two signals. In 
this way, with CellMask™ is possible to identify the cell plasma membrane and 
compare the signal with that due to the Hyp accumulation (that is our PS object of 
study) on the same membrane Fig. 3.1.  With the use of the software Fiji, we are 
able to extrapolate fluorescence profiles of 10-pixel thickness for each cell on each 
frame for both fluorescence channels (red for Hyp and  deep red for CellMask™). 
Then, we analyzed these profiles Matlab custom-written code. Moreover 
CellMask™ fluorescence profile allows us to identify the external membrane 
position and to use it as the reference point. In this way, we are able to quantify the 
Hyp fluorescence emission intensity both on the plasma membrane and in the 
cytoplasm at each frame. From the average values of each profile, in turn averaged 
over all the cells analyzed, we were able to acquire the accumulation curves, over 
time, of the Hyp dye both on the membrane and in the cytoplasm. All measurements 






Fig. 3.1 two-color spinning-disk image of HeLa (a) and PC3 (b) cells. The cell mask 
is in green and  hypericin in red. Scalebar (10 μm) 
  
3.5 HeLa cells transfection and tumor spheroids preparation.  
A stable cell-line expressing miRFP703 [75] fused to histone H2B obtained from 
the HeLa cell culture was selected with 0.7 mg/ml of antibiotic G418. The positive 
cells were sorted by BD FACSAria III (BD Biosciences San Jose, CA, USA) using 
a 633 nm laser line and 780/60 BP emission filter. This stable cell line was used to 
obtain multicellular tumor spheroids using suitable microplates equipped with non-
adhesive surfaces to maintain cells in an un-attached state. The number of cells 
seeded was around 103 – 2x103,
 and they were left in the incubator at 37 °C and 5% 
CO2 for at least 48 h before imaging. 
 
 
3.6 Live/Dead Assay 
HeLa cells were grown in DMEM supplemented with 10% Fetal Bovine Serum and 
1% pen/strep and glutamine. For the viability assay, HeLa cells were seeded on 
Nunc (ThermoFisher) at 60-80% confluence and were used after incubation at 37 
°C and 5% CO2 for 24 - 48 h.  
LIVE/DEAD Viability/Cytotoxicity Kit (ThermoFisher) was performed to 





the medium and added to cell cultures. By intracellular esterase activity, the calcein-
AM is metabolically converted by live cells in a green fluorescent product, termed 
calcein. Instead, Ethidium bromide is readily absorbed by dead cells, labeling DNA 
with a deep red emission. Cells are incubated with these reagents for 10–15 min at 
37 °C and imaged by confocal spinning disk at 37 °C and 5% CO2. 
 
3.7 Cerebellar granule cell culture 
Cerebellar granule cells were obtained from 6 – 8 days old Sprague – Dawley rats 
as described by Robello et al  [76]. In brief, they were planted with a density of 1.5 
– 2.5 · 106 cells/well on coated glass treated with 20 μg/ml Poly – L – Lysine 
(Sigma-Aldrich, St. Louis, MO, USA). 
The neurons were kept at 37 °C in a humidified 95% air/5% CO2 atmosphere and 
grown in 90% basal medium Eagle, 10% fetal calf serum (Sigma-Aldrich, St. Louis, 
MO, USA), 25 mM KCl, 2 mM glutamine and 100 µg/ml gentamicin. 
At 18–24 h from plating, 10 μM cytosine arabinoside (Sigma-Aldrich, St. Louis, 
MO, USA) was added to the culture medium to prevent glial cell growth; at 48 h 
the medium was refreshed and 10 μM cytosine arabinoside was renewed. 
The cells were studied in vitro from the sixth to the tenth day.  
 
3.8 Electrophysiology 
The experiments were performed in the whole-cell patch-clamp configuration with 
an Axopatch 200 B (Axon Instruments, Burlingame, CA, USA). 
The patch micropipettes (5–6 MΩ) were prepared using borosilicate glass 
capillaries (TW 150 – 3 World Precision Instruments Inc., Sarasota, FL, USA) and 
a P–30 puller (Sutter Instruments Co., Novato, CA, USA). 
The currents were measured with a Labmaster D/A, A/D converter driven by 
pClamp 10 software (Axon Instruments, Burlingame, CA, USA) and analyzed with 
pClamp, SigmaPlot (SYSTAT Software, San Jose, CA, USA), MatLab 





The standard external solution (pH 7.4) used for the maintenance of the cells in the 
recording bath contained (in mM): 135 NaCl, 5.4 KCl, 1.8 CaCl2, 1 MgCl2, 5 
HEPES, 10 glucose; the micropipettes were filled with the internal solution 
contained (in mM): 142 KCl, 10 HEPES, 2 EGTA, 2 MgCl2, 3 ATP and the pH was 
adjusted to 7.3 with Tris base. 
The neurotransmitter GABA (Sigma-Aldrich, St. Louis, MO, USA) and the caged 
compound RuBi – GABA (Tocris Cookson Ltd, Bristol, UK) were diluted with an 
external solution at the needed concentration for experiments. 
Where not specified, the final concentration of RuBi – GABA used was 10 µM. 
 
3.9 One and two-photon imaging and uncaging 
The uncaging procedure was performed using a three-channel of Leica TCS SP5 
laser–scanning confocal microscope equipped with 458, 476, 488, 514, 543, and 
633 nm excitation lines, through a plan-apochromatic oil immersion objective 
×63/1.4. The images were acquired with the Leica “LAS AF” software package 
(Leica Microsystems, Germany). 
Chameleon Coherent (Coherent Inc., Santa Clara, CA USA) femtosecond  
Ti:Sapphire laser was used to perform two-photon excitation. 
The laser power was measured at the objective focal point by a power meter 
(PM100A, Thorlabs Inc., Newton, NJ, USA). 
The images in transmitted light were acquired with a scan of 633 nm laser, and as 
a detector was used a photomultiplier.  
For uncaging experiments, Frap Wizard Leica was used to set up the bleach points. 
An image before and after the uncaging was acquired to check that no cellular 
movements occured. 
The currents measured after the photoexcitation of the caged compound directly 
return to the initial value because of the physiological separation of GABA from its 





3.10 Carrier system: Photosensitizer protein binding 
The hydrophobic effect mediates the interaction between PSs and proteins. In 
nature, proteins possess a hydrophobic pocket (i.e. an apolar environment) in which 
a cofactor is usually bound. Since PSs are hydrophobic molecules, typically when 
they are in the presence of a protein deprived of their cofactor they tend to occupy 
the protein pocket by binding to it forming a single complex. (Fig. 3.2) 
 
                                     
 
Fig. 3.2 Representation of binding dynamic. 
 
 The molecule that binds to the protein, thanks to the hydrophobic effect, recovers 
its monomeric state, while the rest of the molecules in aqueous solution tend to form 
aggregates such as dimers, trimers and oligomers of higher rank. 
In the following paragraph we’ll show how it is possible to bind a PS with a protein 
vector. Specifically, we will spectorscopilly study how the PS (Zinc-







ZnPc has a characteristic blue due to the intense absorption band peak in the red 
region at 670nm (Q-band). The more energetic transitions are lower intense, and 
they are found in the blue region of the spectrum around the 340 nm (Soret band). 
But when this PS is dissolved in aqueous solutions (i.e. PBS) it forms aggregates 
which result in a blue shift of the Q band. Furthermore the two peaks at 630nm and 
670nm are due to the formation of the dimeric and monomeric species, 
respectively.[78] 
 
Fig. 3.3  Absorption spectrum (red) and emission spectrum (black) of ZnPc 
dissolved in DMSO  (A)  and in PBS (B) 
 
The intense absorption peak at 670 nm and the high fluorescence signal in Fig. 3.3A 
indicates that ZnPc is soluble in an organic solvent (i.e. DMSO) where it has a 
monomeric conformation. Though, when the ZnPc is dissolved in PBS, the 
absorption spectrum changes, resulting in an increase of the absorption peak at 610 
nm, in comparison to 670 nm peak (Fig. 3.3 B). This conversion is due to the 
formation of the aggregate state of ZnPc (dimer, trimer,[…]), which causes the loss 
of ROS production and fluorescence emission, fundamental characteristic useful in 
PDT.  
To create nanostructures composed of PS-protein complexes, it is added a specific 
quantity of ZnPc dissolved in DMSO (10 M) in a buffer solution in which is 








Fig. 3.4  Absorption spectrum with increasing protein concentration (From 0.6 to 
14.9 M)(A),  emission spectrum with increasing protein concentration. (B) 
 
 Fig. 3.4 shows the measurements of the absorption and fluorescence emissions of 
various samples with different protein concentrations, in which a constant amount 
of ZnPc is added. Since the strong interaction among aggregates results in the 
impossibility of returning to the monomer state even if it is added the protein carrier 
in solution, it was not possible to perform measurements on a single sample, adding 
gradually greater quantities of protein to the initial solution composed of ZnPc 
dissolved in PBS. This means that the interaction between the ZnPc aggregates is 
greater than the hydrophobic interaction that would lead to the formation of the 
protein-PS complex. This does not happen for other photosensitizers such as 
hypericin and curcumin where, to form the complexes, it is possible to add the 
protein carrier after dissolving the photosensitizer in PBS. 
From the absorption spectrum of ZnPc, by increasing the protein concentration, we 
observed an increase in the ratio between the two peaks at 610 nm and 670 nm (Fig. 
3.4 A). This means that there is an increase in the population of ZnPc which is in 







Fig. 3.5  Fluorescence excitation spectrum with increasing protein concentration 
(From 0.6 to 14.9 M). 
 
From the fluorescence excitation (Fig. 3.5) and emission (Fig 3.4 B) spectrum, it is 
possible to deduce the same things. In fact, it is recorded a growth of fluorescence 
emission at the increase of ApoMb concentration. Since aggregates are not 
fluorescent, the behavior suggests the there is an increased population of fluorescent 
ZnPc, which are in a monomeric state due to binding to the protein. 
It is known, that for the common organic molecules the excitation spectrum 
coincides with the absorption spectrum. But in this case, we did not obtain the same 
trend because aggregates are not fluorescent, so they contribute to the absorption 
spectrum while not to the excitation spectrum.  
The only contribute to the excitation spectrum is due to the absorption of the 
monomeric fluorescent ZnPc population that is bound to the protein. 
Integrating all emission spectra at the variation of protein concertation and 
correcting for dilution factor and plotting the results in function of protein 
concentration, we obtain the binding curve (Fig. 3.6) from which we could infer the 
association constant of the complex ApoMb - ZnPc. 𝐾𝑎 =
[𝑅][𝑥]
[𝑅𝑥]








Where [RX] is the complex concentration at equilibrium, while [R] and [X] 
represent respectively the concentrations of protein and free photosensitizers at 
equilibrium. Tipically mioglobin has a single binding site in which is present his 
cofactor called Heme. 
 








Chapter 4: Results and discussion   
 
4.1  RuBi-GABA Uncaging on cerebellar granule cells 
 
Photoactivatable cage compounds remain the primary tools to study membrane 
proteins, such as GABA receptors, with a high spatiotemporal resolution. 
In this work, the photoactivation of caged molecules, in a controlled volume, is used 
for releasing a small amount of GABA neurotransmitters, in a well confined way. 
So, it is possible to choose a cellular region as an object of study, uncage GABA 
neurotransmitters in its proximity, and collect cellular response through 
electrophysiology measurements. 
As can be imagined, some physical parameters such as the quantity, geometry, and 
the modality of GABA release can change, causing, in turn, a change in the neural 
response. 
 The main goal of this part of the thesis work concerns the investigation of all the 
photophysical parameters that change the GABA uncaging, performing a two-
photon uncaging of RuBi-GABA. This allows to understand the mechanism of 
GABA release and to obtain the maximum spatio-temporal control. In detail, this 
study wants to provide the capability to remove the dependence from these 
photophysical parameters for being sure that variations in patch-clamp signals were 
given only from the change of biological parameters. 
 
First of all, we have observed differences induced by the variation of laser power, 
exposure time, XYZ distance from the cell, and different holding potential. All this 
measurement has been achieved using both one and two-photon excitation. 
Moreover, we determined the advantages and disadvantages given by non-linear 
photoactivation.  
 By comparing the values of the current, acquired with the patch-clamp technique, 




to obtain the best physical conditions to be set during the uncaging experiments. 
We observed that the current value increases in several cases, while in others, the 
signal shape changes.   
 Moreover, we performed these measurements both on the same cell and doing 
statistics on more cells, minimizing, in this way errors in order to remove the 
biological sample influence. 
Antagonist test 
The first test performed was the Antagonist test. It is fundamental to confirm the 
activation of GABAA receptors by the uncaged RuBi–GABA molecules.  




Fig. 4.1: Measurement of a current evoked by the photoactivation (458 nm, 100 ms, 
6.7 µW) of 1 µM RuBi – GABA (a); on the same cell, in the presence of 20 µM 
competitive antagonist bicuculline, uncaged 1 µM RuBi – GABA does not activate 
GABAA receptors (b). 
 
 Fig. 4.1 (a) shows the characteristic ion current signal induced from the chloride 
ions passages, because of the activation of the GABAA receptor. The receptor 
activation is due to the 1PE uncaging of RuBi–GABA in the proximity of the 
cerebellar granules.  
When granules are treated with 20 µM of bicuculline, it tends to bind to the GABA 




After the binding, GABAA is not able to open  the channel and no current signal is 
present. (Fig 4.1b).  
This measurement confirms that the RuBi–GABA photoactivation effectively 
generates a GABAA receptors response. 
 
Effect of 1PE and 2PE power changes 
The number of photo-released molecules after photoactivation depends on three 
parameters: the excitation volume size, the concentration of caged molecules in this 
volume, and the laser power. 
As can be imagined, when the laser power is low, only a fraction of caged molecules 
will be uncaged. Increasing the laser power, the amount of uncaged RuBi–GABA 
increases until saturation occurs, i.e. when all the molecules in the excitation 
volume will be uncaged. At this point, the quantification of uncaged molecules 
depends only on their concentration. 
As mentioned before, another significant value is the excitation volume. It is 
possible to control this value by choosing a linear or nonlinear photoactivation. 
Using 1PE (458 nm), RuBi–GABA is uncaged along the all optical path crossing 
the sample, proportionally to the amount of light absorbed in each plane. Using  




Fig. 4.2: Examples of chloride current peaks evoked by 10 µM uncaged RuBi – 
GABA at different laser powers during 1PE (458 nm, 100 ms) (a) and 2PE (750 








































nm, 100 ms) (b) on the same cell. The data are normalized at current value 




Fig. 4.2a and 4.2b show currents measured on the same cell after one and two-
photon uncaging, respectively. 
As already said, increasing the laser power, the uncaged GABA molecules increase 
causing an increase of activated receptors that, in turn, cause a higher current peak  
(fig 4.2 A and B). 
From the comparison of Fig. 4.2 A and 4.2 B, we obtain another information 
regarding the excitation volume. The maximum current peak, after 2PE uncaging, 
results lower, in comparison with 1PE. This is due to the smaller volume of 2PE 
than 1PE case. In fact these two excitation volumes have different geometries: 1PE 
might be approximate as  a large double cone centered in the focal point while 2PE 





Fig. 4.3: Normalized values of current evoked by 10 µM (black squares) and 20 
µM (red dots) uncaged RuBi – GABA at different laser powers during 1PE (458 
nm, 100 ms) (A) and 2PE (750 nm, 100 ms) (B). The data are normalized at 
current value evoked by uncaging of 4.9 µW for 1PE and 77.3 mW for 2PE. 
 
 

















































Fig. 4.3 A and 4.3 B describe the normalized mean values (at least 3 cells) of the 
peak current, in the function of the laser power, at two different concentrations of 
RuBi–GABA (10 and 20 µM). At lower powers, few molecules are released. 
Raising the laser power gradually, uncaged GABA increases until all the molecules 
are photolyzed in the excitation volume, reaching saturation.  
The two different concentration is used for being sure that the saturation comes 
from the uncaging of all the molecules in the excitation volume and not to the 
saturation of the receptors on the plasmatic membrane of the neurons. Both curves 
have the same trend confirming that there is not a receptor’s saturation. The curve 




Exposure time is a parameter that can influence the administration of GABA 
molecules leading to the change in the current signal shape. Moreover, for 1PE, the 
exposure time can also influence the excitation volume size.  
Our first assumption is that caged molecules in the solution spread out. Being 
exposure time longer than the diffusion time, the molecules in the excitation volume 
will be uncaged while spreading out. At the same time, other caged molecules will 
enter in the excitation volume and will be photoactivated. 
Becouse of this mechanism, with long exposure time, a cloud of mixed caged and 







Fig. 4.4: Examples of chloride current peaks evoked by 10 µM uncaged RuBi – 
GABA at different exposure times during 1PE (458 nm, 9.36 µW) (A) and 2PE 
(750 nm, 125 mW) (B) on the same cell. 
 
Experiments were performed (at least on 4 cells) changing the exposure times (1, 
10, 50, 100, 200, 400, 600, 800 ms) for analyzing how may vary the 
electrophysiological measurements. (fig. 4.4A and 4.4B). 
From these measurements  is possible to extrapolate the average peak intensity and 
plot them in functions of  the exposure time: 
 
 
Fig. 4.5: normalized values of current evoked by 10 µM uncaged RuBi – GABA at 
different exposure times during 1PE (458 nm, 9.36 µW) (A) and 2PE (750 nm, 
125 mW) (B), the data are normalized at the current value of the lowest exposure 


















































































Another parameter is the decay value of the peak obtained, interpolating the only 
the decay function with a single exponential (considering only the fastest decay of 
the curve fig 4.4 bis):  
 
Fig. 4.4 bis. Example of  exponential decay fitting of chloride current peaks evoked 
by 10 µM uncaged RuBi – GABA with 2Ph Excitation 
 
 
Fig. 4.6: time of decay in function of the exposure time (τ) during 1PE (458 nm, 
9.36 µW) (A) and 2PE (750 nm, 125 mW) (B); 
 





























Finally, we can plot the full width at half maximum (FWHM) that is characteristic 
of the GABA administering: 
 
Fig. 4.7: the difference between FWHM and FWHM at 1 ms in the function of the 
exposure time during 1PE (458 nm, 9.36 µW) (A) and 2PE (750 nm, 125 mW) (B). 
 
Using 1PE and protracting the exposure time, the intensity of the current peak (fig. 
4.4A and 4.5A) and the time of decay (fig. 4.6A) increase until a plateau value. 
Considering the full width at half maximum (FWHM) of the signal it results in a 
linear trend when the exposure time increases (fig. 4.7A). 
With 2PE, the behavior changes: the peak of current and the time decay does not 
vary (fig. 4.4B, 4.5B, and 4.6B), but the FWHM (Fig.7 B) linearly rises with the 
exposure time. 
This analysis explains how the behavior of neuronal response changes using 1PE 
or 2PE. The increase of the exposure time during 1PE raises the dimension of the 
uncaging volume causing an increase of the current intensity (fig. 4.5A). 
This is correlated to the probability of photoactivation in the far planes from the 
focal point. In these planes the photon density is smal, thus the probability of 
uncaging molecules is low. 
On the other hand, rising the exposure time, the probability increases, and it 
produces a raise of the excitation volume. 
This volume increment increases the number of uncaged molecules leading to a 
raise in the number of the receptors involved in the signal and consequently extends 
the decay time of the signal. (fig. 4.6A). 





























This behavior does not happen for 2PE (Fig. 4.5 B), where the excitation probability 
peculiarly depends on laser power.    
For both 1PE and 2PE when the power increases the full width at half maximum 
broadens too. However, in the first case is due to the mix of two effects: decay time 
(Fig. 4.6 A) and neurotransmitter administration become longer because we 
increase the exposure time. (fig. 4.7A).  
When 2PE is used, the behavior changes: in fact, as shown in fig. 4.5B and 4.6B, 
the current intensity and decay time remain constant because the excitation volume 
of the two-photon does not significantly vary by varying the exposure time. 
Therefore, the population of receptors involved in the signal is constant. 
Only the full width at half maximum (fig. 4.7B) linearly increases with the exposure 
time because the neurotransmitter is administered for a longer time. This is 
confirmed by the fact that for a variation of the exposure time there is the same 
variation of the full width at half maximum.  
 
X, Y, Z distance from the target 
Changing the distance between the uncaging point and the cell, the amount of 
uncaged GABA that will binds GABAA receptors on the plasma membrane will 
vary. This is due to the isotropic diffusion of photolyzed molecules from the 








Fig. 4.8: Example of uncaging point variations on X–Y axis 
 
Changing the uncaging distance on the X–Y axes (fig. 4.8), the measured currents, 







Fig. 4.9: Currents related to the example of fig. 4.8 during 2PE (750 nm, 100 ms, 
77.3 mW) (A) and 1PE (458 nm, 100 ms, 9.36 µW) (B). 
 
Moreover, from the graphs in Fig. 4.9 A-B is possible to observe not only a change 
of current intensity but also a change of the rising current in the function of distance 




Fig. 4.10: Peak value for 1PE (458 nm, 100 ms, 9.36 µW) and 2PE (750 nm, 100 
ms, 77.3 mW)to vary of XY distance; normalized data (at least 4 cells) at the 
current value nearest of the cell (A). The rising peak in function time during 1PE 
(458 nm, 9.36 µW) at 50 μm uncaging distance interpolated with Eq. 4.1 .(B) 
 
As shows in the following equation, the diffusion of the molecules can be 









  (4.1) 
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with C as molecule concentration, D as diffusion coefficient, x as the distance from 
the point source, t as the time and A as an arbitrary constant [80] 
Increasing the uncaging distance increases the rise time. Since we uncage away 
from the cell, not all uncaged molecules will reach the receptors at the same 
time(fig. 4.9 A, B and 4.10 B). 
The theoretical value of the GABA diffusion coefficient evaluated for GABA 
molecules with the Stokes-Einstein equation, using water as medium and a 
concentration of 10 µM, is 7 · 10–10 m2 · s–1. 
The value obtained from the measurements performed in the experiments, as shown 
in fig. 4.10 B, is (6 ± 3) · 10–10 m2 · s–1 which results in good agreement with the 
theoretical value. Therefore, the variations of the current peak are due to diffusion 
phenomena. The diffusion coefficient was calculated at different distances between 
20 to 90µm. 
In Fig. 4.10 are shown the current peak values, as a function of the distance from 
the cellular membrane both for experiments performed with 1PE (red dots) and 2PE 
(black squares). Varying the uncaging point in X and Y (fig. 4.8) and moving from 
the target, the number of molecules that reach the receptor is gradually lesser due 
to the isotropic diffusion of the compound in solution. When uncaging is produced 
using 2PE, the current peaks show a faster decrease, compared to 1PE, as the 
distance on the X-Y plane increases. This confirms that two-photon microscopy 
results more sensitive than one–photon. 
Whereas, when we uncage in different positions on Z-axis (Fig. 4.11), current peaks 





Fig. 4.11: Normalized data (at least 3 cells)  current value at different Z-
Distance: red dots for 1PE (458 nm, 100 ms, 9.36 µW) (red dots) and black 
squares for 2PE (750 nm, 100 ms, 77.3 mW). 
 
In the first 10 µm from the coverslip surface, the current peak for 2PE remains 
constant. This is due to the Z-dimension of the cerebellar granule that is of the order 
of 10 µm. Going to further distance, the current value decreases. (Black dots of fig. 
4.11) because the photolyzed molecules, that can arrive at the receptors, are lesser 
because of the diffusion. The same result was also obtained when we changed the 
distance in X and Y.  
This does not happen for 1PE where the current increase in the first points until 
achieves a plateau (red dots of fig. 4.11). 
The increase of the current is due to the moving, in the solution, of the lower 
excitation cone that, in the beginning, was under the glass slice. After that, the 
current trace reaches a plateau because the gain of the uncaged molecules of the 






The experiment conducted, consists of an I - V currents in different conditions.  
Changing different holding potentials and collecting the current signals is possible 
to investigate if and how endogenous GABA and uncaged RuBi–GABA have 
different effects on current traces. The measurements made with 10 µM GABA 
show an ohmic trend ( 4.12) [81].  



















Fig. 4.12: Current – potentials curve obtained after the administration of 10 µM 
GABA. The data (at least 4 cells) are normalized at the current values of –60 mV. 
The potential range goes from –60 mV to +60 mV with a step of 20 mV. 
 
 
Other experiments (on 4 cells) were carried out with photolyzed 10 µM RuBi–
GABA (1PE, 458 nm, 9 µW, 100 ms) (Fig.4.13). The photoactivation point was set 
near the cell target, and the currents were recorded applying a voltage bias spanning 






Fig. 4.13: Current – potentials curve obtained after uncaging of 10 µM RuBi – 
GABA with 1PE (458 nm, 9 µW) and 100 ms of exposure time. The data are 
normalized at the current values of –60 mV. The potential range goes from –60 
mV to +60 mV with a step of 20 mV. The experiments (at least 4 cells) were 
performed near (black squares) and at 30 µm from the cell (red dots). 
 
The data (black squares) are reported in Fig. 4.13: at positive bias, the current peak 
values deviate from the ohmic behavior; the current module is lower than the 
negative one. 
Then, RuBi–GABA was uncaged 30 µm far away from the plasma membrane, and 
this resulted in currents with the same ohmic behavior both for negative and positive 
bias, similar to experiments performed with endogenous GABA (red dots fig. 4.13). 
The current response in function of the potentials in cerebellar granule cells usually 
shows an ohmic trend (fig. 4.12), this also occurs at a great distance, but not when 




It is possible to suppose that this behavior derives from a local change of the 
potential due to the uncaging: the caged group, in fact, shows a positive charge in 
aqueous solution, which might lead to electrostatic interaction with chloride ions 
[82]. 
This hypothetic binding would entail a depletion of the chloride concentration in 
the external solution near the cell. 
Therefore, it would bring to a decrease of currents at positive potentials, that is 




4.2 Photosensitizer action on tumor cells  
Intracellular distribution of PSs may play a key role in the different degrees of 
phototoxicity of Hyp and Hyp-apoMb. Fluorescence microscopy is one of the main 
methods to investigate the localization and diffusion of molecules or proteins in a 
living system [83], and it is useful to understand PSs uptake by cultured cells. 
In this section, we studied different PSs that have several properties of interest for 
photodynamic therapy (PDT). Moreover, we will see how these PSs combined with 
a suitable protein carrier increase their efficacy.  
In particular, the use of protein carrier systems can increase the rate of accumulation 
of hypericin PS or can increase the ZnPc compatibility and bioavailability.  
Furthermore, we will also see that by using curcumin it will be possible to change 
the areas of intracellular accumulation and photostability, and finally, it will be 
shown how the use of Zinc Myoglobin VIP as a protein carrier allows you to give 
selectivity to PDT which is one of the fundamental requirements to damage only 
cancer cells. 







Hypericin is well-known for its different photodynamic effects. These effects were 
discovered when grazing animals ingested St. John's wort (i.e Hypericum Plant) 
and showed effects such as severe skin irritation, high temperatures bodily, and in 
extreme cases, even death. This phenomenon took the name of hypericism because 
it causes severe and robust events of photosensitivity due to ingestion  hypericin 
contained in the Hypericum. Since hypericism is an oxygen-dependent condition, 
its photodynamic action was soon recognized. 
Like many other photosensitizers, Hyp is insoluble in water and forms aggregates, 
which dramatically influence the photo-physics of the compound, resulting in the 
quenching of the excited states that lead to triplet state formation, consequently 
impairing the photosensitizing properties. 
Binding of Hyp to proteins increases its solubility in physiological media [84,85], 
and thanks to their high biocompatibility, proteins appear to be a promising delivery 
vehicle ensuring good bioavailability of the drug and preservation of its 
photodynamic action against target cells [86,87]. In particular, Hyp binds with 
moderate affinity (Kd = 4.2±0.8 M) to apomyoglobin (apoMb) forming a self-
assembled, non-covalent complex, endowed with good fluorescence quantum yield 
(F = 0.140.02) and efficient singlet oxygen photosensitization (Δ = 0.140.03) 
[74]. 
For comparison, the fluorescence and singlet oxygen quantum yields of Hyp in 
organic solvents, such as DMSO, are F = 0.350.02 and Δ = 0.280.05, 
respectively [74].  
Hyp-apoMb presents a higher efficacy of Hyp and results in more phototoxic cell 
viability tests [88]. For understanding which mechanism produces these 
differences, we performed some microscopic tests. 
 
Cellular distribution of Hyp-apoMb by STED imaging  
Super-resolution microscopy methods [89] [60] can allow the study of PS 






Fig. 4.14 Photoinduced damage to HeLa and PC3 cells incubated with Hyp-
apoMb.  Effect of illumination by STED imaging on HeLa (Panels a) and PC3 
cells (Panels b) incubated for 30 minutes with Hyp-apoMb (0.5 µM Hyp, 1.5 µM 
apoMb) after 0, 5 and 10 minutes of irradiation. STED images collected under 
excitation at 566 nm and detection at 605\70 nm. The STED beam was at 715 nm, 
power 8 mW, and dwelled time 0.05 ms.  Panels c show close-up images on 
swelling and vesicle formation as a consequence of the photoinduced damage on 
the plasma membrane on HeLa cells. Scale bars, 10 µm. 
 
In fact,  the inherent bright fluorescence emission by Hyp could be exploited to 
collect STED images of bacterial cells loaded with Hyp-apoMb [74][90][59].  
In this case, STED nanoscopy, was applied to follow the uptake of the PS and to 
distinguish the possible different mechanisms that occur in cells when it is present 
either Hyp or Hyp-ApoMb. 
STED images of HeLa and PC3 cells incubated with Hyp-ApoMb (0.5 µM Hyp, 




min). These images highlight the accumulation of the PS on the plasma membrane 
as well as within the cytoplasm, whereas the cell nucleus results in devoid of 
fluorescence emission. The behavior is the same for both types of cells. The intense 
fluorescence emission indicates that the molecules are in the monomeric state, 
which represents a significant advantage over other nanostructured PSs systems for 
which a clear tendency to aggregate was sometimes evidenced. [91]. Fluorescent 
molecules are photoactive, and the photo-oxidative damages depend on molecular 
distribution. 
When using STED microscopy, cell exposure to strong laser light produces a 
quickly extensive cell damage. The plasma membrane is damaged a few minutes 
after illumination, as shown in the central panels of Fig. 4.14 (a and b) when 
compared to non-irradiated HeLa and PC3 cells (Fig. 4.14 a and b, left panels). 
Damages consist of the formation of swelling areas in the plasma membrane in 
localized regions. The cell size increases and vesicles are  formed, and they 
eventually detach from the cell. In particular, Fig. 4.14, panels c, offers close-up 
views on extensive swelling regions where the photo-oxidative damage 
concentrates. The left and center images of panel c show regions where vesicles are 
forming (at points indicated by the arrows) and detach (within the dashed line box).  
An area with an intense vesicle formation is reported in panel c. There is a large 
variability of vesicle diameters. In the same panel, it is also evident the loss of 
integrity of several regions of the plasma membrane. 
 
Spinning disk imaging: photosensitizer uptake of Hyp and Hyp-apoMb.  
As shown, super-resolution images obtained by exploiting STED nanoscopy 
demonstrate that  under intense illumination the photo-induced oxidative stress 
strongly damages the plasma and internal membranes. This imaging method is 
unsuitable to follow PSs cellular uptake in time.  The intense STED laser beam 
(fluence rate ∼10MW/cm2 in the focal plane) produce a severe photo-oxidation 
damage that far exceeds the standard experiments encountered for PDT applications 
on cultured cells where the light intensity is on the order of 10-30 mW/cm2. Such 
damage generates a progressive and concomitant change in the transport properties 




Therefore, we decided to sacrifice spatial resolution in favor of a less invasive 
imaging technique. Spinning confocal disk microscopy seems a good compromise, 
in fact, allow to keep sectioning capability and an excellent resolution. This 
methodology leads to a substantial reduction in the frame acquisition time (one 
frame in 0.2 s), the number of averages (only 2 to optimize the signal-to-noise ratio), 
and laser power (132 W). Additionally, to decrease photodamages, it was used 
low PSs concentrations (50nM), which is high enough to observe a detectable 
action against cells. Overall, this decreased the photo-oxidative damage during 
image acquisition and allowed us to follow the uptake of the PS by cells over a ~50-
minute time window (every minute for the first 11 minutes and one frame in 0.2 s 
every 5 minutes for 40 minutes ), without any interfering photo-oxidative damage. 
Fig. 4.15 panels a and b, shows examples of Hyp and Hyp-apoMb uptake time 
sequences by HeLa cells. A simple visual inspection of the images allows 
appreciating a remarkable difference in the PS loading mechanism. In the case of 
Hyp administered from a concentrated DMSO solution, the fluorescence grows 
homogeneously in the whole cell structure. On the other hand, when Hyp-ApoMb 
is delivered to the cell culture, fluorescence appears to be initially concentrated 
mostly at the plasma membrane, where the PS concentration appears higher than in 





Fig. 4.15. Uptake dynamics of Hyp and Hyp-apoMb. 
Comparison between the accumulation of Hyp (50 nM) in HeLa cells at selected 
delays when the PS is delivered bound to apoMb (Panels a) and when delivered 
without a carrier (Panels b). Experiments on PC3 cells gave similar results. 
Images were collected with a spinning disk microscope with excitation at 561 nm 
(power 132  W). It Was acquired one image (0.2 s frame acquisition time) every 
minute for the first 10 minutes and one image (0.2 s frame acquisition time) every 
5 minutes for the last 40 minutes. Scale bar 10μm (Panels a and b). 
Panels c-f. Hypericin fluorescence intensity for the plasma membrane and for the 
cytoplasm calculated from images collected at increasing delay after Hyp or Hyp-
apoMb was added to the solution.Cellmask deep red was used to mark the 
mebrane to obtain a reference (see Materials and methods section 3.4) . Plots 
refer to HeLa cells (c, d) and PC3 cells (e, f) treated with Hyp (c, e) and with 
Hyp-apoMb (d, f). Intensity values are calculated for several cells, and the error 
bars represent cell-to-cell variability. The intensity curves are normalized to the 
maximum fluorescence value observed for the internal part of the cell. 
 
In order to quantitatively study the variations in time of the fluorescence intensity 
on the plasma membrane after injection of Hyp or Hyp-apoMb to the buffer where 
cells are held, cells were labeled by “CellMask™ Deep Red Plasma Membrane 
Stains.” This stain allows maintaining a reference for the position of the membranes 




to determine the fluorescence emission intensity at selected positions (See materials 
and method 3.4). Then the fluorescence intensity at the plasma membrane and in 
the cell interior (cytoplasm and inner membranes) was plotted in function of time 
(Fig 4.15 panels c-f). 
The trends of the Hyp uptake when delivered in complex with ApoMb or alone 
show significant differences. In particular, it is evident that the rise fluorescence at 
the plasma membrane (red symbols in Fig. 4.15 panels d and f) is much faster when 
cells are treated with Hyp-apoMb. The time scale of the concentration increase at 
the plasma membrane is about 5-10 minutes from the administration. Moreover, the 
presence of the protein carrier leads to higher concentrations of the PS on the 
plasma membrane than on the inner membranes. This represents an advantage when 
it is essential to induce photodynamic action in short times after the drug 
administration. 
Since ApoMb is a water-soluble protein without any known specific affinity for 
plasma membrane components, it remains to be understood whether the higher PS 
uptake involves unreported interaction with the cell structure. In order to further 
comprehend the action of the complex Hyp-apoMb, we covalently labeled 
Fluorescein-5-Isothiocyanate (FITC) to ApoMb. Such labeling allowed us to study 
the fate of the ApoMb and the pay load Hyp independently during the uptake 
process in HeLa and PC3 cells.  
In Fig. 4.16 for PC3 cells, green fluorescence from FITC-labelled ApoMb is 
appreciable only from the buffer medium and is not detectable either on the cell 
membrane or inside the cell. In contrast, the red fluorescence emission from Hyp is 
observed from the plasma membrane as well as from the internal membranes and 
reflects the distribution (after incubation and uptake) reported in Fig 4.14 and 4.15. 
Similar results were obtained for HeLa cells. These findings suggest that apoMb 
mostly acts as a passive carrier that facilitates the delivery of Hyp to the membranes 
by preventing aggregation in the aqueous phase. The higher affinity of the PS for 
the lipid phase leads to the fast partitioning of Hyp, leaving the unloaded protein in 
solution.  
The water-soluble protein carrier is very useful in preventing Hyp aggregation, and 




the wells, the Hyp, in the monomeric state, bound to ApoMb is rapidly and 
efficiently transferred to the plasma membrane. It speeds up cell loading and allows 
us to increase the bioavailability of the PS compound. This mechanism is not 
present when Hyp is added to the solution without the protein carrier. In these 
conditions, right after injection to the cell-bathing buffer, PSs result extensively 
aggregated, and the rescue of aggregated PSs molecules is a slower and less 
efficient process.  Thus, we can conclude that Hyp-ApoMb remarkably increases 
PSs bioavailability. 
 
Fig. 4.16.  Hyp-apoMb-FITC imaging. Spinning Disk Fluorescence Imaging of 
PC3 cells treated with Hyp-apoMb (a) in the FITC channel (500-550 nm) shows 
the distribution of apoMb, in comparison with (b) the red channel (575-605 nm) 
that shows Hyp distribution. (c) Overlay of the two images [ApoMb] = 10 M, 
[Hyp] = 3 M. The incubation time was 1 hour. Scale bars are 10μm. 
FITC channel is excited at 488nm, Exposure time 400ms, power 324W; 
Hypericin is excited with the laser at 561nm, exposure time 100ms, power 567W, 
for both channels the pixel size is 0.14m. 
 
 
Tumor spheroid treated with PS.  
We have shown that uptake of the PS is faster and more efficient for Hyp-ApoMb 
than for Hyp in bi-dimensional cell cultures, but it is not obvious that this advantage 
is preserved in tumor tissues. Thus, we used tumor spheroids as a three-dimensional 
model system to study the uptake of the PS. Spheroids are considered a good model 
for small solid tumors before neovascularization [92][93]. HeLa cells were 
transfected with the far red-emitting fluorescent protein miRFP703 [75] fused to 
histone H2B to visualize the cell nucleus and to monitor the size of the spheroid. 
Since such a fluorescent protein has excitation and emission spectra in the far red, 




spheroids. In Fig 4.17, was showed the effects of Hyp and Hyp-apoMb on HeLa 
spheroids.  
In the control spheroids, which are not exposed to the microscope light (Fig. 4.17 
a), we did not observe any evidence of morphological damages induced by 
phototoxicity; in fact, they grow normally. Although the size of Hyp-apoMb is 
significantly larger than that of Hyp, steric effects do not impair penetration of the 
drug. Thus, uptake through the spheroid occurs both for Hyp (Fig. 4.17 b) and for 
Hyp-apoMb (Fig. 4.17 d). However, as noted, for cultured single-layer cells, the 
concentration of the fluorescent species is higher when Hyp-apoMb is used (Fig. 
4.17 d). The difference between the two cases is at least one order of magnitude. 
After irradiation, the cells in the outer layer die, and in the short term (1 week), the 
growth of the spheroids is completely blocked (right images in panels c, and e). A 
few documented difficulties hamper a more quantitative estimation of the efficiency 
of the phototoxicity on the spheroid. These include low oxygen content in the inner 
parts of the spheroid [94] and uneven distribution of the PS, which is found at lower 
concentrations in the center [95][96]. Initial accumulation at the spheroid rim was 
also reported for treatments of spheroids with hypocrellin-loaded liposomes, 
followed by a more even distribution of the PS at longer times [97]. This delayed 
kinetics most likely derives from the high affinity of Hyp for liposomes that may 
transiently hold the photosensitizers and prevent binding to the plasma membrane 
of tumor cells.  
Definitely, Hyp-ApoMb potentially offers advantages in terms of delivery rate, 
since fluorescence is also detected in the center of the spheroid (although at a lower 
concentration than at the periphery) after just one-hour incubation time (Fig. 4.17 
d). The moderate affinity of Hyp for apoMb and the high affinity for lipid 
membranes mean that, when Hyp-apoMb is in the presence of tumor cells, Hyp will 





Fig. 4.17  Effects of Hyp and Hyp-apoMb on HeLa tumor spheroids upon light 
irradiation. Spinning disk imaging of HeLa cells permanently transfected with 
miRFP703-H2B (shown in cyan-hot) (a-e) and treated with Hyp (1 μM) (b and c), 
and with Hyp-apoMb (1 μM) (d and e). The samples in a, b, and c were incubated 
1h with Hyp. The samples in d and e were incubated 1h with Hyp-apoMb. Panels 
a, c and e, are time sequences at days 0, 1, and 6. Samples were illuminated at 
day 0 for 5 minutes at 561 nm with power 3.37 mW. Each image is composed of 
inset with a 3x magnification of the squared area defined with a dashed line, and 
by an orthogonal projection of the middle plane, yz. Scale bar is 50 μm, voxel size 




A particular class of PSs, called Phthalocyanines (PCs), were objects of study for 
PDT applications. The high absorbance maximum in the near-infrared spectrum, 
necessary for an optimal tissue light penetration, the molar extinction coefficient at 
674 nm of 2,8 × 105(cm-1 M-1), the triplet lifetime of the order of microsecond and 
the high singlet oxygen quantum yield are characteristics that make PCs ideal 







PCs form various chelates state with several metallic ions, giving a longer triplet 
lifetime and allowing high singlet oxygen quantum yield (ΦΔ) that for example for 
Zinc phthalocyanine (ZnPc) reaches the value of 0.67 [98].  
The main drawback of these molecules is the formation of aggregates that cause a 
substantial decrease in molecule bioavailability involving a drop in their efficacy. 
Typically is possible to bind Phthalocyanine to Apomyglobin, obtaining a stable 
complex with an association constant of  (9.0 ± 0.6) × 104 M-1 [77]. When we 
compared cells treated with PS bound to ApoMb (Fig.4.18) was observed an 
increase of phototoxicity respect to only PS administration. Illumination without 
PS is not toxic. Measurements were done at the same PSs concentration [100 nM] 





Fig. 4.18 Pc3 illuminated without PS, cellular damages [100nM] ZnPc, and 
ZnPc+ApoMb [100nM]   transmission and fluorescence channels at zero, five, 
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ten, and fifteen minutes (Scale bar 10µm). Image acquisition was made with a 
frame rate of one per minute for 19 minutes, laser power of (389W), and 
exposure (500 mS) with 100x objective 1.4NA. The images are 512x512 with a 
pixel size of 0.249m/px. 8 averages were performed to minimize the noise. All 
measurements were done with an incubation system. 
 
ZnPc and ZnPc+ApoMb uptake 
At this point we also investigated cellular uptake and the accumulation differences 
between the membrane and the cytoplasm both for ZnPc and ZnPc+ApoMb 
complex. The study of PSs accumulation in time was performed using spinning disk 
confocal microscopy (Fig 4.19).  
 
Fig. 4.19 Uptake of ZnPc [100nM] in HeLa cells (a) and PC3 cells (c); 
ZnPc+ApoMb [10nM] in HeLa cells (b) and Pc3 cells (d) 
 
We acquired one frame every 2 minutes for the first 16 minutes, and finally, one 
frame every 5 minutes in order to minimize the cellular damages. Moreover, a 




used. It was crucial to set these conditions because a higher concentration of the 
complex ApoMb-ZnPc causes serious cellular damage, while for much low PS 
concentration we have too low fluorescent signals. This is an additional aspect that 
shows the difference in the bioavailability of these two species. The ZnPc 
accumulation curves (Fig.4.19 a-c) are characterized by a fast decrease of the 
fluorescent signal and loss of the PS molecules. In addition, PS aggregation in 
solution occurred. Aggregation is an irreversible process and the the replacement 
with new monomeric molecules did not occur.  
Instead, using the complex ZnPc-ApoMb (Fig. 4.19 b-c), it is possible to notice an 
increase of bioavailability. Indeed, the accumulation curves show an equilibrium 
between the complexes ZnPc-ApoMb and ZnPc-cells, the concentration of our PSs 
remains constant involving a phototoxicity increase. 
Toxicity test 
Finally, three-colors large images were acquired using live HeLa cells. The first 
two channels show live (green) and dead (red) cells, while the last one shows ZnPc 
(Cyan). Dark toxicity test was performed (Fig. 4.20 A-B-C-D) for analyzing the 
biocompatibility and bioavailability of our PS molecules (Fig. 4-20 A-D) and the 
complexes (Fig. 4.20 B). 
Besides, the phototoxicity test in the absence of the complex (Fig. 4.20 F), used as 
a negative control (Fig. 4.20 E), was performed in order to compare the potential 



























































Fig. 4.20. Dead cells red, live cells green, ZnPc cyan, scale bars are 500 μm. 
Hela cell with ZnPc 500nM solved in PBS (A), ZnPc+ApoMb 100nM (B), ZnPc 
500nM solved in DMSO (C), 5.2l DMSO (D),  illumination in the center region 
for 5min at 647nm with power of 2.5mW in presence of ZnPc-ApoMb complexes 
(E) and without PS (F) Image acquisition was performed using  4x objective 
0.45NA for the large image and a 20X for the inset. Images are 512x512 pixels. 
 
These measurements show that ZnPc is only soluble in DMSO though in this 
condition (Fig. 4.20 C) our PS is not compatible with the biological sample. Indeed, 
in the injection region we noticed cellular death due to DMSO as well as not 
uniform distribution of ZnPc. Moreover, at a longer distance from the injection 
point, we observed an increase of the PSs aggregation (i.e. less fluorescence).  
Moreover, it is not possible to use ZnPc in aqueous solution, because of aggregates 
formation, which drastically decreases the bioavailability of our PS (Fig. 4.20 A). 
Instead, using the complex ZnPc-ApoMb allows dissolving ZnPc in aqueous 
solutions efficiently. In this way, we obtain uniform distribution in the biological 
sample, an increase in biocompatibility and bioavailability (Fig. 4.20 B). Also, 
these data demonstrate the high toxicity of our complex when excited with light, 
while outside the illuminated area, our complexes result atoxic for specimens (Fig. 
4.20 E). In fact, the control test shows that illuminating without the  administration 





In the myoglobin the heme group cannot produce singlet oxygen [31], but the heme 
iron chelation can occur. During periods of iron insufficiency or impaired iron 
utilization by the organism, zinc becomes an alternative metal substrate for 
ferrochelatase, leading to increased ZnPP (Zinc ProtoPorphirin) formation [99].  
These molecules have a quantum yield of a single oxygen generation of ΦΔ =0.91 
[100]. Such a relevant value is of significant importance and makes this molecule a 




The high quantum yield for singlet oxygen generation corresponds to a lower 
fluorescent quantum yield (ΦF =0.03) [31]. 
 
Cellular uptake study  
Since this PS is directly based on myoglobin is hydrophilic, and does not 
accumulate spontaneously in the cell membranes. 
 
Fig. 4.23  Fast confocal spinning disk fluorescence imaging of HeLa cells treated 
with Zinc-Myoglobin at 0, 19 and 59 min of accumulation time. Time-lapse one 
frame each 2 min for the first 14min and 1 frame each 5 min to 69 min. Excitation 
561 nm, emission 592/22 nm, exposure time 100 ms. For all the images, the pixel's 
area is 512x512, and the pixel size is 0.23 m.  0 time without PS. 
  
 
So myoglobin re-formed with Zn-protoporphyrin IX (ZnMb) is characterized by 
high efficiency of production of singlet oxygen, but, as is shown in Fig. 4.23, it has 
no specificity for cells. In fact, ZnPP IX molecules result diffused in all the samples, 
and no accumulation in the cells is observed. This compromises the efficiency of 
the PS for PDT. 
However, it is possible to engineer the protein part of this PS with a specific peptide 




The peptide, called Vasoactive Intestinal Peptide (VIP), is a neurotransmitter and a 
peptide hormone belonging to the glucagon-secretin family, located mainly in 
intestinal and nervous tissues. Among its functionalities, there are vasodilation, 
prolactin release, and intestinal and pancreatic secretion [101]. Furthermore, the 
VIP can carry out a transport action towards neoplastic tissues since the presence 
of its receptors in different tumor cells has been identified [102]. 
This peptide bonded to ZnMb protein allows the accumulation of these proteins in 
tumor cells, causing cell death, as shown in Fig. 4.24 
 
Fig. 4.24  Fast confocal spinning disk fluorescence imaging of HeLa cells treated 
with Zinc-Myoglobin VIP at 0, 19 and 59 min of accumulation time. Time-lapse 
one frame each 2 min for the first 14min and 1 frame each 5 min to 69 min. 
Excitation 561 nm, emission 592/22 nm, exposure time 100 ms. For all the 





Turmeric (Curcuma longa rhinzomes), commonly used as a spice, is well 
documented for its medicinal properties in Indian and Chinese systems of medicine. 
It has been widely used for the treatment of several diseases. Epidemiological 




reduce the risk of some form of cancers and may have other protective biological 
effects in humans. These biological effects of turmeric have been attributed to its 
constituent called curcumin. Curcumin was widely studied for its anti-
inflammatory, anti-angiogenic, antioxidant, wound healing, and anti-cancer effects. 
[103] 
Curcumin exhibits a variety of biological and photochemical activity, including 
phototoxicity. [104] 
This PS is unstable in water, and its spectral properties undergo major changes 
within minutes from the preparation of the solutions. On the contrary, in ethanol 
solutions, curcumin spectral properties are stable over days. 
The spectral instability observed in PBS solutions poses limitations in the use of 
this PS for applications in PDT and for antibacterial treatments.  
Oxidation of the compound may be prevented or at least made less efficient if a 
delivery agent is used to solubilize curcumin in water [105]. 
Using BSA, Curcumin results stable over at least 5 hours and comparing the use of 
the only curcumin with curcumin-BSA, the concentration at which we have a 50% 
reduction of cell viability results 3-times lower when curcumin is bound to the 
carrier. [105]. This difference can be led back to a different accumulation of the PS 
using BSA as a carrier. 
 
Mytotraker Colocalization study  
When curcumin is delivered to cultured cells using a concentrated ethanol solution, 






Fig. 4.21.  Fast confocal spinning disk fluorescence imaging of HeLa cells 
incubated 15 min with mitoTracker Deep red [0.3 M], and 10 min with curcumin 
[15 M].  Curcumin channel: excitation 405 nm, emission 460/60, exposure time 
50 ms.  Mitotraker channel: excitation 633 nm, emission 700/75 nm, exposure 
time 200 ms. For all the images, the pixel's area is 512x512, and the pixel size is 
0.16 m.  Scale bar 10 m. 
 
Fig. 4.21 shows that fluorescence emission from curcumin co-localizes with the 
fluorescence emission from MitoTracker red. Thus, the accumulation of curcumin 
when delivered without a carrier occurs at the mitochondria level. Curcumin shows 
preferred association in model lipid bilayers with cardiolipin, which is a lipid 
molecule exclusively localized in the inner mitochondrial membrane. In keeping 
with our findings, fluorescence from curcumin was demonstrated to co-localize 
with mitochondria within cells. [106] The interaction of curcumin through 
cardiolipin-mediated interactions with mitochondrial membranes was suggested to 
be an underlying responsible factor for the high efficacy of this compound against 
metabolic diseases. Moreover, when curcumin accumulates inside mitochondrial 
membranes can also have adverse effects on cells. Curcumin and curcumin 
derivatives targeting mitochondria exhibited significant cytotoxicity towards 
several cancer cell lines, inducing significant ROS generation, cell-cycle arrest, 
and apoptosis. [107] 
 
Fig. 4.22. Fast confocal spinning disk fluorescence imaging of HeLa cells 
incubated 15 min with mitoTracker Deep red [0.3 M], and 10 min with 
curcumin-BSA [15 M]. Curcumin channel: excitation 405 nm, emission 460/60, 
exposure time 50 ms.  Mitotraker channel: excitation 633 nm, emission 700/75 
nm, exposure time 200 ms. For all the images, the pixel's area is 512x512, and the 





Fig. 4.22 shows that when HeLa cells are incubated with curcumin-BSA the 
distribution of the compounds appears different from that observed for curcumin 
alone. While it co-localizes with mitochondria there is a diffuse fluorescence in a 
large area in the cytoplasm, from curcumin in addition to. The homogeneous 
loading of the cell appears to be a direct consequence of the higher bioavailability 
of the photoactive compound when delivered bound to BSA.  
The lack of aggregation and the increased stability of curcumin mean that the 
compound is accessible at higher concentrations and for longer times so that the 
uptake from cells is more diffuse. In the presence of HeLa cells, it is expected that 
fully photoactive curcumin is efficiently transferred to the cell structures by the 
carrier protein, due to the higher affinity of the compound for lipids and possibly 
for other macromolecules endowed with hydrophobic binding sites.  
The broader distribution of curcumin-BSA may be responsible for the more 






Chapter 5: Conclusions 
 
5.1 Rubi-GABA uncaging 
In conclusion, the study of the uncaging process and its critical parameters allows 
understanding its influence in the electrophysiological measurements. 
Never the less it demonstrates that it can be used to map the distribution of 
functional GABAA receptors in different regions of neurons, using uncaging points 
in specific areas such as the cell body, axons or dendrites (fig. 4.7). 
 
 
Fig. 4.7: Currents related to several uncaging points in different parts of a neuron 
during 2PE (750 nm, 100 ms, 77.3 mW) of 10 µM RuBi – GABA; among the 
measurements, it waited that the current returned to the initial status. 
 
In the figure several current measurements after a sequential uncaging of 10 µM 
RuBi – GABA are pointed out in different parts of a neuron: moving the 
photoactivation point from the cell body, the current decreases, suggesting that the 




The future aims of this approach are: (i) map the receptor subtypes with 
fluorescence staining for the different subunits and with antagonist molecules that 
block the receptor binding sites and (ii)  study how the receptor density may change 
in a precise area after treatment with drugs such as benzodiazepines. 
 
5.2 Photosensitizers  
The study of photosensitizers coupled with protein carriers shows that PSs form 
stable complexes with protein carriers such as ApoMb and BSA. Using these 
molecules, we were able to induce cellular death by light in a specific region of 
biological specimens. Complex formation preserves the monomeric photoactivable 
state of the PS and increases its biocompatibility, bioavailability, and phototoxicity, 
even at low concentrations upon illumination.  
Delivery of PS with protein has an impact on the intracellular distribution of the 
compound. For example, we have seen that when curcumin is delivered without the 
protein carrier, it is mainly localized in the mitochondria. While, when curcumin is 
bound to BSA, the cellular distribution appears more homogeneous, likely 
associated with a variety of target structures.  
In addition, it is possible to modify the PS accumulation dynamics. We showed that 
the Hyp-ApoMb complex allows a preferential accumulation in the external 
membrane, compared to the only Hyp. It results efficient when applied to 3D tissues 
such as tumor spheroids. The use of protein carriers produces an increase in 
bioavailability of the PS.  
Finally, it was possible to engineer proteins with a particular linker that would allow 
them to be selectively targeted to tumor cells (i.e. being able to distinguish healthy 
cells from tumor cells), thus, increasing the sensitivity and selectivity of the PDT. 
All these characteristics allow increasing the efficacy and the phototoxicity of these 
PSs that are essential to reduce the concentration of PSs necessary for cell death, 
avoiding side effects. In summary, the use of protein carrier systems makes PSs 
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